PKG2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00571 | S83 | Sugiyama | DDX3X DBX DDX3 | sKDKDAyssFGsRsDsRGKssFFsDRGsGsRGRFDDRGRsD |
| O14579 | S99 | Sugiyama | COPE | PELQAVRMFADyLAHEsRRDsIVAELDREMsRSVDVTNTTF |
| O14617 | S658 | Sugiyama | AP3D1 PRO0039 | DERPRAVFHEEEQRRPKHRPsEADEEELARRREARKQEQAN |
| O14618 | S267 | Sugiyama | CCS | DGLTIWEERGRPIAGKGRKEsAQPPAHL_____________ |
| O14974 | S692 | Sugiyama | PPP1R12A MBS MYPT1 | PVRDEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIG |
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14974 | T696 | Sugiyama | PPP1R12A MBS MYPT1 | EEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSRS |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15067 | S1053 | Sugiyama | PFAS KIAA0361 | RGLRERMGPSYCLPPTFPKAsVPREPGGPsPRVAILREEGS |
| O15067 | S215 | Sugiyama | PFAS KIAA0361 | LDSWDLDFYTKRFQELQRNPstVEAFDLAQsNsEHSRHWFF |
| O15085 | T1292 | Sugiyama | ARHGEF11 KIAA0380 | GERPEQEDMGLCSLEHLPPRtRNsGIWEsPELDRNLAEDAS |
| O15143 | S328 | Sugiyama | ARPC1B ARC41 | KAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCSQFCTT |
| O15212 | T107 | Sugiyama | PFDN6 HKE2 PFD6 | IKRYESQLRDLERQsEQQREtLAQLQQEFQRAQAAKAGAPG |
| O15372 | S290 | Sugiyama | EIF3H EIF3S3 | QQQQKHQYQQRRQQENMQRQsRGEPPLPEEDLsKLFKPPQP |
| O43847 | S94 | Sugiyama | NRDC NRD1 | ENSRVARLGADEsEEEGRRGsLsNAGDPEIVKsPsDPKQYR |
| O60293 | S42 | Sugiyama | ZFC3H1 CCDC131 KIAA0546 PSRC2 | LEDGEIsDDDNNSQIRSRsssSsSGGGLLPYPRRRPPHSAR |
| O60343 | T749 | Sugiyama | TBC1D4 AS160 KIAA0603 | ENEIRQDTASESSDGEGRKRtSstCsNEsLsVGGTSVTPRR |
| O60841 | S107 | Sugiyama | EIF5B IF2 KIAA0741 | NEEEFtsKDKKKKGQKGKKQsFDDNDsEELEDKDsKSKKTA |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S183 | Sugiyama | EIF5B IF2 KIAA0741 | GsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKN |
| O75369 | S2532 | Sugiyama | FLNB FLN1L FLN3 TABP TAP | ASKVTSKGAGLSKAFVGQKssFLVDCSKAGSNMLLIGVHGP |
| O75494 | S133 | Sugiyama | SRSF10 FUSIP1 FUSIP2 SFRS13A TASR | yDRYRRSRSRSYERRRsRsRsFDyNYRRsYsPRNSRPTGRP |
| O76021 | S314 | Sugiyama | RSL1D1 CATX11 CSIG PBK1 L12 | RNFEKQKERKKKRQQARKtAsVLsKDDVAPEsGDtTVKKPE |
| O76074 | S102 | ELM | PDE5A PDE5 | PLQQsPRADNSAPGTPTRKIsAsEFDRPLRPIVVKDSEGTV |
| O95155 | S105 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | LsssPsNsLEtQsQsLsRsQsMDIDGVSCEKsMsQVDVDsG |
| O95613 | S44 | Sugiyama | PCNT KIAA0402 PCNT2 | QRKTKGDSSHSEKKTAKRKGsAVDAsVQEEsPVTKEDsALC |
| O95714 | S2928 | Sugiyama | HERC2 | ILLGRIRAEEEDLAAVPFLAsDNEEEEDEKGNSGsLIRKKA |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P00533 | T430 | SIGNOR|PSP | EGFR ERBB ERBB1 HER1 | WPENRTDLHAFENLEIIRGRtKQHGQFSLAVVSLNITSLGL |
| P00533 | T693 | PSP | EGFR ERBB ERBB1 HER1 | IVRKRtLRRLLQERELVEPLtPsGEAPNQALLRILKETEFK |
| P00568 | S58 | Sugiyama | AK1 | stGDLLRSEVSSGSARGKKLsEIMEKGQLVPLETVLDMLRD |
| P01023 | S273 | Sugiyama | A2M CPAMD5 FWP007 | LYTYGKPVPGHVTVSICRKYsDAsDCHGEDSQAFCEKFSGQ |
| P04075 | S346 | Sugiyama | ALDOA ALDA | EEYVKRALANsLACQGKytPsGQAGAAAsEsLFVsNHAy__ |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04075 | Y364 | Sugiyama | ALDOA ALDA | tPsGQAGAAAsEsLFVsNHAy____________________ |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04626 | T686 | EPSD|PSP | ERBB2 HER2 MLN19 NEU NGL | VLGVVFGILIKRRQQKIRKYtMRRLLQETELVEPLtPsGAM |
| P04792 | S78 | SIGNOR | HSPB1 HSP27 HSP28 | LPPAAIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVs |
| P04792 | S82 | SIGNOR|Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P04792 | T143 | SIGNOR | HSPB1 HSP27 HSP28 | KHEERQDEHGyIsRCFTRKYtLPPGVDPTQVSSsLsPEGtL |
| P05204 | S29 | ELM | HMGN2 HMG17 | DAKGDKAKVKDEPQRRsARLsAKPAPPKPEPKPKKAPAKKG |
| P05362 | S43 | Sugiyama | ICAM1 | GPGNAQTSVSPSKVILPRGGsVLVTCstsCDQPKLLGIETP |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05783 | S305 | Sugiyama | KRT18 CYK18 PIG46 | QSAEVGAAETTLTELRRtVQsLEIDLDsMRNLKAsLENsLR |
| P05787 | S330 | Sugiyama | KRT8 CYK8 | MNRNISRLQAEIEGLKGQRAsLEAAIADAEQRGELAIKDAN |
| P06733 | Y44 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | LFtsKGLFRAAVPsGAstGIyEALELRDNDKtRYMGKGVSK |
| P06737 | S430 | Sugiyama | PYGL | KHLDRIVALFPKDVDRLRRMsLIEEEGSKRINMAHLCIVGS |
| P06748 | S242 | Sugiyama | NPM1 NPM | sKGQEsFKKQEKtPKtPKGPssVEDIKAKMQAsIEKGGsLP |
| P06899 | S37 | Sugiyama | H2BC11 H2BFR HIST1H2BJ | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | S320 | Sugiyama | LDHB | GLtsVINQKLKDDEVAQLKKsADtLWDIQKDLKDL______ |
| P07195 | T302 | Sugiyama | LDHB | YGIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsAD |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S399 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNLVKK |
| P07900 | S460 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | QFSKNIKLGIHEDsQNRKKLsELLRyytsAsGDEMVsLKDY |
| P07900 | S623 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tyGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsII |
| P07900 | S63 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IFLRELIsNssDALDKIRyEsLtDPsKLDsGKELHINLIPN |
| P08238 | S206 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | KEDQtEyLEERRVKEVVKKHsQFIGyPItLyLEKEREKEIs |
| P08238 | S391 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | PEYLNFIRGVVDsEDLPLNIsREMLQQsKILKVIRKNIVKK |
| P08238 | S45 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | MSLIINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKL |
| P08238 | S452 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AFSKNLKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEy |
| P08238 | S460 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | GIHEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQ |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S58 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IFLRELIsNAsDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| P08238 | S615 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | tyGWTANMERIMKAQALRDNstMGyMMAKKHLEINPDHPIV |
| P08581 | S985 | EPSD|PSP | MET | GsELVRYDARVHtPHLDRLVsARsVsPttEMVsNEsVDyRA |
| P08670 | S325 | Sugiyama | VIM | NNDALRQAKQESTEYRRQVQsLtCEVDALKGtNEsLERQMR |
| P09132 | S69 | Sugiyama | SRP19 | IQDVCSAVGLNVFLEKNKMYsREWNRDVQYRGRVRVQLKQE |
| P09525 | S125 | Sugiyama | ANXA4 ANX4 | DEGCLIEILASRTPEEIRRIsQtYQQQYGRSLEDDIRSDTS |
| P09619 | S254 | SIGNOR|PSP | PDGFRB PDGFR PDGFR1 | MCIVIGNEVVNFEWTYPRKEsGRLVEPVTDFLLDMPYHIRS |
| P09619 | S712 | SIGNOR|PSP | PDGFRB PDGFR PDGFR1 | yLHRNKHTFLQHHSDKRRPPsAELysNALPVGLPLPSHVSL |
| P09972 | S45 | Sugiyama | ALDOC ALDC | APGKGILAADEsVGsMAKRLsQIGVENtEENRRLYRQVLFs |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG47 | S57 | Sugiyama | UBB | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P0CG48 | S57 | Sugiyama | UBC | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGM |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P10412 | S55 | Sugiyama | H1-4 H1F4 HIST1H1E | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P10412 | S58 | Sugiyama | H1-4 H1F4 HIST1H1E | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P10809 | S398 | Sugiyama | HSPD1 HSP60 | LDVttsEyEKEKLNERLAKLsDGVAVLKVGGtsDVEVNEKK |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P13569 | S660 | ELM | CFTR ABCC7 | FsSKLMGCDSFDQFSAERRNsILTETLHRFsLEGDAPVSWT |
| P13569 | S700 | ELM | CFTR ABCC7 | TEtKKQsFKQTGEFGEKRKNsILNPINsIRKFsIVQKTPLQ |
| P13569 | S737 | ELM | CFTR ABCC7 | TPLQMNGIEEDSDEPLERRLsLVPDSEQGEAILPRIsVIST |
| P13569 | S768 | ELM | CFTR ABCC7 | ILPRIsVISTGPTLQARRRQsVLNLMTHSVNQGQNIHRKTT |
| P13569 | S795 | ELM | CFTR ABCC7 | HSVNQGQNIHRKTTAsTRKVsLAPQANLTELDIYsRRLsQE |
| P13569 | S813 | ELM | CFTR ABCC7 | KVsLAPQANLTELDIYsRRLsQEtGLEISEEINEEDLKECF |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13639 | S732 | Sugiyama | EEF2 EF2 | DAIHRGGGQIIPtARRCLyAsVLtAQPRLMEPIyLVEIQCP |
| P13861 | S58 | Sugiyama | PRKAR2A PKR2 PRKAR2 | TRLREARAPAsVLPAAtPRQsLGHPPPEPGPDRVADAKGDs |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P14625 | S106 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | MKLIINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENAL |
| P14866 | S544 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | LGVKRPSSVKVFSGKsERsssGLLEWEsKSDALETLGFLNH |
| P15880 | S190 | Sugiyama | RPS2 RPS4 | WGNKIGKPHTVPCKVTGRCGsVLVRLIPAPRGtGIVsAPVP |
| P16333 | S85 | Sugiyama | NCK1 NCK | ASIVKNLKDTLGIGKVKRKPsVPDsAsPADDsFVDPGERLy |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16402 | S56 | Sugiyama | H1-3 H1F3 HIST1H1D | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16402 | S59 | Sugiyama | H1-3 H1F3 HIST1H1D | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16403 | S55 | Sugiyama | H1-2 H1F2 HIST1H1C | AsGPPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEK |
| P16403 | S58 | Sugiyama | H1-2 H1F2 HIST1H1C | PPVsELItKAVAASKERsGVsLAALKKALAAAGyDVEKNNS |
| P16930 | S164 | Sugiyama | FAH | KENALMPNWLHLPVGYHGRAssVVVSGTPIRRPMGQMKPDD |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17544 | S44 | Sugiyama | ATF7 ATFA | LAVHKHKHEMTLKFGPARtDsVIIADQtPtPtRFLKNCEEV |
| P17844 | S519 | Sugiyama | DDX5 G17P1 HELR HLR1 | AGKRGGFNTFRDRENYDRGYssLLKRDFGAKTQNGVYSAAN |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P18858 | S901 | Sugiyama | LIG1 | DKQPEQATTSAQVACLYRKQsQIQNQQGEDsGsDPEDTY__ |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P20290 | S173 | Sugiyama | BTF3 NACB OK/SW-cl.8 | QLGADsLtsLRRLAEALPKQsVDGKAPLAtGEDDDDEVPDL |
| P22087 | S124 | Sugiyama | FBL FIB1 FLRN | DALVTKNLVPGEsVyGEKRVsIsEGDDKIEyRAWNPFRSKL |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P23527 | S37 | Sugiyama | H2BC17 H2BFH H2BFN HIST1H2BO | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGISS |
| P24534 | S141 | Sugiyama | EEF1B2 EEF1B EF1B | ERLAQYESKKAKKPALVAKssILLDVKPWDDEtDMAKLEEC |
| P25054 | S1389 | Sugiyama | APC DP2.5 | PKsPPEHYVQETPLMFsRCTsVSsLDSFESRSIASSVQSEP |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P25789 | T10 | Sugiyama | PSMA4 HC9 PSC9 | ___________MSRRyDsRttIFsPEGRLYQVEYAMEAIGH |
| P26232 | T657 | Sugiyama | CTNNA2 CAPR | EDDsDFEQEDYDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P26641 | T287 | Sugiyama | EEF1G EF1G PRO1608 | EQALAAEPKAKDPFAHLPKstFVLDEFKRKysNEDtLsVAL |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P29350 | S553 | SIGNOR|PSP | PTPN6 HCP PTP1C | EsEyGNITyPPAMKNAHAKAsRtssKHKEDVyENLHTKNKR |
| P29350 | S556 | SIGNOR|PSP | PTPN6 HCP PTP1C | yGNITyPPAMKNAHAKAsRtssKHKEDVyENLHTKNKREEK |
| P29350 | S557 | SIGNOR|PSP | PTPN6 HCP PTP1C | GNITyPPAMKNAHAKAsRtssKHKEDVyENLHTKNKREEKV |
| P29401 | S104 | Sugiyama | TKT | AVWAEAGFLAEAELLNLRKIssDLDGHPVPKQAFtDVATGs |
| P29401 | S473 | Sugiyama | TKT | AtEKAVELAANTKGICFIRTsRPENAIIyNNNEDFQVGQAK |
| P29474 | S1177 | EPSD|PSP | NOS3 | EDIFGLTLRTQEVTSRIRtQsFsLQERQLRGAVPWAFDPPG |
| P29474 | S633 | EPSD|PSP | NOS3 | FNsISCSDPLVssWRRKRKEssNtDSAGALGTLRFCVFGLG |
| P29474 | T495 | EPSD|PSP | NOS3 | YQPDPWKGSAAKGTGITRKKtFKEVANAVKISASLMGTVMA |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30086 | T51 | Sugiyama | PEBP1 PBP PEBP | GAAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDP |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P31939 | S554 | Sugiyama | ATIC PURH OK/SW-cl.86 | VSISSDAFFPFRDNVDRAKRsGVAyIAAPSGsAADKVVIEA |
| P32119 | S112 | Sugiyama | PRDX2 NKEFB TDPX1 | KEGGLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFII |
| P32929 | S377 | SIGNOR|EPSD|PSP | CTH | ASVLKNDRDVLGISDtLIRLsVGLEDEEDLLEDLDQALKAA |
| P33316 | S120 | Sugiyama | DUT | PsKRARPAEVGGMQLRFARLsEHAtAPTRGsARAAGYDLYS |
| P33778 | S37 | Sugiyama | H2BC3 H2BFF HIST1H2BB | KAITKAQKKDGKKRKRsRKEsysIyVyKVLKQVHPDTGISS |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35221 | T658 | Sugiyama | CTNNA1 | LDDsDFEtEDFDVRsRtsVQtEDDQLIAGQsARAIMAQLPQ |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P37837 | S13 | Sugiyama | TALDO1 TAL TALDO TALDOR | ________MsssPVKRQRMEsALDQLKQFTTVVADTGDFHA |
| P39019 | Y48 | Sugiyama | RPS19 | LKVPEWVDtVKLAKHKELAPyDENWFytRAAstARHLYLRG |
| P39019 | Y54 | Sugiyama | RPS19 | VDtVKLAKHKELAPyDENWFytRAAstARHLYLRGGAGVGs |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P39023 | S265 | Sugiyama | RPL3 OK/SW-cl.32 | HRGLRKVACIGAWHPARVAFsVARAGQKGYHHRTEINKKIY |
| P41236 | S24 | Sugiyama | PPP1R2 IPP2 | STAsHRPIKGILKNKtsttssMVAsAEQPRGNVDEELSKKs |
| P42677 | T74 | Sugiyama | RPS27 MPS1 | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43243 | S195 | Sugiyama | MATR3 KIAA0723 | RDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRsQEsGyyD |
| P43243 | S234 | Sugiyama | MATR3 KIAA0723 | yDRMDyEDDRLRDGERCRDDsFFGEtsHNyHKFDsEyERMG |
| P43243 | T150 | Sugiyama | MATR3 KIAA0723 | EDKItPENLPQILLQLKRRRtEEGPtLsyGRDGRsAtREPP |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46459 | S207 | Sugiyama | NSF | KAENSSLNLIGKAKTKENRQsIINPDWNFEKMGIGGLDKEF |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P46777 | S230 | Sugiyama | RPL5 MSTP030 | yLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAHAAIREN |
| P46779 | S115 | Sugiyama | RPL28 | HMIRKNKYRPDLRMAAIRRAsAILRSQKPVMVKRKRTRPTK |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49327 | S1997 | Sugiyama | FASN FAS | DGLLENQTPEFFQDVCKPKYsGtLNLDRVTREACPELDYFV |
| P49419 | S84 | Sugiyama | ALDH7A1 ATQ1 | EVIttyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWAD |
| P49588 | S237 | Sugiyama | AARS1 AARS | LVFIQYNREADGILKPLPKKsIDtGMGLERLVsVLQNKMSN |
| P49736 | S229 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sHGHNVFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLP |
| P49840 | Y279 | Sugiyama | GSK3A | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P49841 | Y216 | Sugiyama | GSK3B | LKLCDFGSAKQLVRGEPNVsyICsRYYRAPELIFGATDYTS |
| P50552 | S157 | ELM | VASP | EVEQQKRQQPGPSEHIERRVsNAGGPPAPPAGGPPPPPGPP |
| P50552 | S239 | ELM | VASP | GGAGAPGLAAAIAGAKLRKVsKQEEAsGGPTAPKAESGRSG |
| P50552 | T278 | ELM | VASP | SGGGGLMEEMNAMLARRRKAtQVGEKtPKDEsANQEEPEAR |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51858 | S107 | Sugiyama | HDGF HMG1L2 | WEIENNPtVKASGYQSsQKKsCVEEPEPEPEAAEGDGDKKG |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52298 | Y14 | Sugiyama | NCBP2 CBP20 PIG55 | _______MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQEK |
| P52943 | S115 | Sugiyama | CRIP2 CRP2 | AARAEERKAsGPPKGPsRAssVttFtGEPNtCPRCSKKVYF |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P60174 | S21 | Sugiyama | TPI1 TPI | MAPSRKFFVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVV |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62241 | S160 | Sugiyama | RPS8 OK/SW-cl.83 | KRSKKIQKKYDERKKNAKIssLLEEQFQQGKLLACIASRPG |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62269 | S96 | Sugiyama | RPS18 D6S218E | QYKIPDWFLNRQKDVKDGKysQVLANGLDNKLREDLERLKK |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62424 | T84 | Sugiyama | RPL7A SURF-3 SURF3 | QRQRAILyKRLKVPPAINQFtQALDRQTAtQLLKLAHKYRP |
| P62701 | T247 | Sugiyama | RPS4X CCG2 RPS4 SCAR | VIGKGNKPWIsLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62805 | S48 | Sugiyama | H4C1 H4/A H4FA HIST1H4A; H4C2 H4/I H4FI HIST1H4B; H4C3 H4/G H4FG HIST1H4C; H4C4 H4/B H4FB HIST1H4D; H4C5 H4/J H4FJ HIST1H4E; H4C6 H4/C H4FC HIST1H4F; H4C8 H4/H H4FH HIST1H4H; H4C9 H4/M H4FM HIST1H4I; H4C11 H4/E H4FE HIST1H4J; H4C12 H4/D H4FD HIST1H4K; H4C13 H4/K H4FK HIST1H4L; H4C14 H4/N H4F2 H4FN HIST2H4 HIST2H4A; H4C15 H4/O H4FO HIST2H4B; H4C16 H4-16 HIST4H4 | QGItKPAIRRLARRGGVKRIsGLIyEETRGVLKVFLENVIR |
| P62899 | S15 | Sugiyama | RPL31 | ______MAPAKKGGEKKKGRsAINEVVtREytINIHKRIHG |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62906 | T9 | Sugiyama | RPL10A NEDD6 | ____________MSSKVsRDtLyEAVREVLHGNQRKRRKFL |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P62917 | T146 | Sugiyama | RPL8 | LARAsGNyAtVIsHNPEtKKtRVKLPSGSKKVISSANRAVV |
| P62937 | T157 | Sugiyama | PPIA CYPA | NIVEAMERFGsRNGKTSKKItIADCGQLE____________ |
| P62942 | T22 | Sugiyama | FKBP1A FKBP1 FKBP12 | GVQVEtIsPGDGRtFPKRGQtCVVHytGMLEDGKKFDSSRD |
| P62979 | S123 | Sugiyama | RPS27A UBA80 UBCEP1 | LKYYKVDENGKIsRLRRECPsDECGAGVFMAsHFDRHyCGK |
| P62979 | S57 | Sugiyama | RPS27A UBA80 UBCEP1 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGA |
| P62987 | S57 | Sugiyama | UBA52 UBCEP2 | PPDQQRLIFAGKQLEDGRtLsDyNIQKEstLHLVLRLRGGI |
| P63146 | S142 | Sugiyama | UBE2B RAD6B UBCH1 | ANSQAAQLYQENKREYEKRVsAIVEQsWNDS__________ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | S209 | Sugiyama | YBX1 NSEP1 YB1 | RRRRFPPyyMRRPYGRRPQysNPPVQGEVMEGADNQGAGEQ |
| P67809 | T108 | Sugiyama | YBX1 NSEP1 YB1 | QtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEAANVtGP |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68104 | T432 | Sugiyama | EEF1A1 EEF1A EF1A LENG7 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68363 | S439 | Sugiyama | TUBA1B | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| P68363 | Y432 | Sugiyama | TUBA1B | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P78362 | S494 | Sugiyama | SRPK2 | GSPLTEQEESSPSHDRSRtVsAsstGDLPKAKTRAADLLVN |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| Q01970 | S1105 | SIGNOR|ELM|iPTMNet|EPSD | PLCB3 | EMNEREKKELQKILDRKRHNsIsEAKMRDKHKKEAELTEIN |
| Q01970 | S26 | SIGNOR|ELM|iPTMNet|EPSD | PLCB3 | PGVHALQLEPPTVVETLRRGsKFIKWDEETSSRNLVTLRVD |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q03393 | S19 | SIGNOR|iPTMNet|EPSD|PSP | PTS | __MSTEGGGRRCQAQVSRRIsFsASHRLYSKFLSDEENLKL |
| Q04695 | S32 | Sugiyama | KRT17 | SsIKGSSGLGGGsSRTsCRLsGGLGAGsCRLGSAGGLGSTL |
| Q04917 | S145 | Sugiyama | YWHAH YWHA1 | KMKGDYYRYLAEVASGEKKNsVVEAsEAAyKEAFEISKEQM |
| Q05048 | S377 | Sugiyama | CSTF1 | TQAVFNHtEDyVLLPDERTIsLCCWDSRTAERRNLLSLGHN |
| Q05639 | T432 | Sugiyama | EEF1A2 EEF1AL STN | VESFSQYPPLGRFAVRDMRQtVAVGVIKNVEKKSGGAGKVT |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06481 | S111 | Sugiyama | APLP2 APPL2 | CQEMYPELQITNVMEANQRVsIDNWCRRDKKQCKSRFVTPF |
| Q07157 | S1153 | Sugiyama | TJP1 ZO1 | EEPAPLsyDsRPRYEQAPRAsALRHEEQPAPGyDtHGRLRP |
| Q07866 | S524 | Sugiyama | KLC1 KLC KNS2 | QRVAEVLNDPENMEKRRsREsLNVDVVKYESGPDGGEEVSM |
| Q08211 | S1026 | Sugiyama | DHX9 DDX9 LKP NDH2 | HKEKRKILTTEGRNALIHKssVNCPFssQDMKYPSPFFVFG |
| Q08211 | S449 | Sugiyama | DHX9 DDX9 LKP NDH2 | FIQNDRAAECNIVVTQPRRIsAVsVAERVAFERGEEPGKSC |
| Q08AD1 | S1313 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | sLNtGDNEsVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWE |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q09161 | S22 | Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q09161 | T21 | Sugiyama | NCBP1 CBP80 NCBP | MSRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEK |
| Q12965 | T935 | Sugiyama | MYO1E MYO1C | VLQVSIGPGLPKNSRPTRRNttQNtGySsGtQNANyPVRAA |
| Q12982 | S114 | Sugiyama | BNIP2 NIP2 | EFEWEDDLPKPKTTEVIRKGsItEyTAAEEKEDGRRWRMFR |
| Q13206 | S829 | Sugiyama | DDX10 | sEDMENKISDTKKKQGMKKRsNsEVEDVGPTsHNRKKARWD |
| Q13237 | S11 | Sugiyama | PRKG2 PRKGR2 | __________MGNGSVKPKHsKHPDGHsGNLTTDALRNKVT |
| Q13237 | S110 | Sugiyama | PRKG2 PRKGR2 | GGSPLQAsPDKVPLEVHRKtsGLVSLHSRRGAKAGVSAEPT |
| Q13237 | S18 | Sugiyama | PRKG2 PRKGR2 | ___MGNGSVKPKHsKHPDGHsGNLTTDALRNKVTELERELR |
| Q13237 | S285 | Sugiyama | PRKG2 PRKGR2 | IMRRTAQARDEQYRNFLRSVsLLKNLPEDKLTKIIDCLEVE |
| Q13237 | S431 | Sugiyama | PRKG2 PRKGR2 | DDEKRHAKRSMSNWKLSKALsLEMIQLKEKVARFSSSSPFQ |
| Q13237 | T109 | Sugiyama | PRKG2 PRKGR2 | QGGSPLQAsPDKVPLEVHRKtsGLVSLHSRRGAKAGVSAEP |
| Q13247 | S297 | Sugiyama | SRSF6 SFRS6 SRP55 | RSRSPKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsP |
| Q13625 | T739 | Sugiyama | TP53BP2 ASPP2 BBP | EALRKKLSNAPRPLKKRssItEPEGPNGPNIQKLLYQRTTI |
| Q14135 | S59 | Sugiyama | VGLL4 KIAA0121 | SALsSHRTGPPPIsPSKRKFsMEPGDEDLDCDNDHVSKMSR |
| Q14151 | S818 | Sugiyama | SAFB2 KIAA0138 | QHYGDDRHGHGGPPERHGRDsRDGWGGyGsDKRLsEGRGLP |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14157 | S852 | Sugiyama | UBAP2L KIAA0144 NICE4 | LDyysIPFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASS |
| Q14247 | S282 | Sugiyama | CTTN EMS1 | QKDyKTGFGGKFGVQsERQDsAAVGFDyKEKLAKHEsQQDy |
| Q14432 | S312 | Sugiyama | PDE3A | sssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKRG |
| Q14432 | T311 | Sugiyama | PDE3A | RsssVVsAEMSGCSSKSHRRtsLPCIPREQLMGHSEWDHKR |
| Q14566 | S271 | Sugiyama | MCM6 | VPDVSKLSTPGARAEtNsRVsGVDGyEtEGIRGLRALGVRD |
| Q14671 | S709 | Sugiyama | PUM1 KIAA0099 PUMH1 | LGGFGTAVANSNTGSGSRRDsLtGSsDLYKRTSSSLTPIGH |
| Q14697 | S190 | Sugiyama | GANAB G2AN KIAA0088 | VNARGLLEFEHQRAPRVsQGsKDPAEGDGAQPEEtPRDGDK |
| Q14847 | S146 | SIGNOR|ELM|iPTMNet|EPSD|PSP|Sugiyama | LASP1 MLN50 | FEKSRMGPsGGEGMEPERRDsQDGssyRRPLEQQQPHHIPt |
| Q14847 | S61 | iPTMNet|EPSD|Sugiyama | LASP1 MLN50 | MKNYKGYEKKPYCNAHyPKQsFtMVADtPENLRLKQQSELQ |
| Q14847 | S99 | Sugiyama | LASP1 MLN50 | ELQsQVRYKEEFEKNKGKGFsVVADtPELQRIKKTQDQIsN |
| Q14980 | S1991 | Sugiyama | NUMA1 NMP22 NUMA | QPIQIAEGTGITTRQQRKRVsLEPHQGPGtPEsKKATSCFP |
| Q15036 | S437 | Sugiyama | SNX17 KIAA0064 | PLLEsPDAtREsMVKLSsKLsAVsLRGIGsPSTDASAsDVH |
| Q15036 | S440 | Sugiyama | SNX17 KIAA0064 | EsPDAtREsMVKLSsKLsAVsLRGIGsPSTDASAsDVHGNF |
| Q15042 | S340 | Sugiyama | RAB3GAP1 KIAA0066 RAB3GAP | PQCLLGDFVTEFFKICRRKEsTDEILGRSAFEEEGKETADI |
| Q15185 | S72 | Sugiyama | PTGES3 P23 TEBP | EIDLFHCIDPNDsKHKRtDRsILCCLRKGEsGQsWPRLTKE |
| Q15424 | S794 | Sugiyama | SAFB HAP HET SAFB1 | EREGQHYPERHGGPERHGRDsRDGWGGyGsDKRMsEGRGLP |
| Q15428 | S153 | Sugiyama | SF3A2 SAP62 | LFQIDYPEIAEGIMPRHRFMsAyEQRIEPPDRRWQYLLMAA |
| Q15654 | S400 | Sugiyama | TRIP6 OIP1 | DATSQIHCIEDFHRKFAPRCsVCGGAIMPEPGQEETVRIVA |
| Q15785 | S93 | Sugiyama | TOMM34 URCC3 | DCTSALALVPFSIKPLLRRAsAyEALEKYPMAYVDYKTVLQ |
| Q15942 | S505 | Sugiyama | ZYX | DQANRPHCVPDYHKQYAPRCsVCSEPIMPEPGRDETVRVVA |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16778 | S37 | Sugiyama | H2BC21 H2BFQ HIST2H2BE | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKQVHPDTGIss |
| Q3B726 | S316 | Sugiyama | POLR1F TWISTNB | GsDssGyQsDHKKKKKKRKHsEEAEFtPPLKCsPKRKGKSN |
| Q53EL6 | S76 | Sugiyama | PDCD4 H731 | NAKAKRRLRKNssRDsGRGDsVsDsGsDALRSGLtVPtsPK |
| Q58FF6 | S34 | Sugiyama | HSP90AB4P | IFLQELISNASDALDKIRyEsLtDPsKLDGGKELKIDIIPN |
| Q58FF7 | S185 | Sugiyama | HSP90AB3P HSP90BC | KEDQtEyLEERRVKEVVKKHsQFIGyPItLyLEKEQDKEIs |
| Q58FF7 | S488 | Sugiyama | HSP90AB3P HSP90BC | TYGWTANMEQIMKAQALRDNstMGyMMAKKHLEINPDHPIM |
| Q58FF7 | S58 | Sugiyama | HSP90AB3P HSP90BC | IFLQELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q58FF8 | S58 | Sugiyama | HSP90AB2P HSP90BB | IFLWELISNASDALDKIRyEsLtDPsKLDsGKELKIDIIPN |
| Q5T0N5 | S488 | Sugiyama | FNBP1L C1orf39 TOCA1 | NEAWLSEVEGKTGGRGDRRHssDINHLVtQGREsPEGsytD |
| Q5T1M5 | S1162 | Sugiyama | FKBP15 KIAA0674 | EAGstVAGAALRPsHHsQRssLsGDEEDELFKGATLKALRP |
| Q5T5C0 | S692 | Sugiyama | STXBP5 LLGL3 | YGSNDPYRREPRSPRKsRQPsGAGLCDIsEGtVVPEDRCKS |
| Q5TAX3 | S1384 | Sugiyama | TUT4 KIAA0191 ZCCHC11 | DAGHVRRECPEVKLARQRNssVAAAQLVRNLVNAQQVAGSA |
| Q5VT52 | S1070 | Sugiyama | RPRD2 KIAA0460 HSPC099 | TATDQQQQEEHYRIETRVsssCLDLPDSTEEKGAPIETLGy |
| Q5VTE0 | T432 | Sugiyama | EEF1A1P5 EEF1AL3 | VEsFSDyPPLGRFAVRDMRQtVAVGVIKAVDKKAAGAGKVT |
| Q6DN03 | S37 | Sugiyama | H2BC20P HIST2H2BC | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6DRA6 | S37 | Sugiyama | H2BC19P HIST2H2BD | KAVTKAQKKDGKKRKRSRKEsysIyVyKVLKRVHPDTGIWC |
| Q6GYQ0 | S860 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | DEFIAERLRSGNASTMTRRGssPGsLEIPKDLPDILNKQNQ |
| Q6P158 | S605 | Sugiyama | DHX57 | SLNGPPEKVANIICTQPRRIsAISVAERVAKERAERVGLTV |
| Q6P1J9 | S174 | Sugiyama | CDC73 C1orf28 HRPT2 | AARLEGHKEGIVQTEQIRSLsEAMsVEKIAAIKAKIMAKKR |
| Q6P2Q9 | T1404 | Sugiyama | PRPF8 PRPC8 | RVWAEYALKRQEAIAQNRRLtLEDLEDSWDRGIPRINTLFQ |
| Q6PD62 | S932 | Sugiyama | CTR9 KIAA0155 SH2BP1 | KKGGEFDEFVNDDtDDDLPIsKKKKRRKGsGsEQEGEDEEG |
| Q6PJG9 | S585 | Sugiyama | LRFN4 SALM3 | sPTPKAHPPRsPPPRPQRsCsLDLGDAGCYGYARRLGGAWA |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6UXD5 | S719 | Sugiyama | SEZ6L2 PSK UNQ1903/PRO4349 | CQKIMTCADPGEIANGHRTAsDAGFPVGSHVQYRCLPGYSL |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q6ZN18 | S206 | Sugiyama | AEBP2 | DEGYGTGGGGSSATSGGRRGsLEMssDGEPLSRMDSEDSIS |
| Q6ZRI6 | S455 | Sugiyama | C15orf39 FP6578 | EAEEKTWLPSCRKEKLQPRLsEHsGPPIVIRDsPVPCtPPA |
| Q71U36 | S439 | Sugiyama | TUBA1A TUBA3 | SEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy________ |
| Q71U36 | Y432 | Sugiyama | TUBA1A TUBA3 | GMEEGEFSEAREDMAALEKDyEEVGVDsVEGEGEEEGEEy_ |
| Q71UM5 | T74 | Sugiyama | RPS27L | VLCVGCSTVLCQPTGGKARLtEGCsFRRKQH__________ |
| Q7KZI7 | S40 | Sugiyama | MARK2 EMK1 | TLGHLDSKPssKSNMIRGRNsAtsADEQPHIGNyRLLKTIG |
| Q7Z4S6 | T862 | Sugiyama | KIF21A KIAA1708 KIF2 | DKVAGKVTRKLsssDAPAQDtGssAAAVETDASRTGAQQKM |
| Q7Z4V5 | S454 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | VRPEEKQQAKPVKVERTRKRsEGFsMDRKVEKKKEPSVEEK |
| Q7Z5L9 | S360 | Sugiyama | IRF2BP2 | EANGANGSKAVARTARKRKPsPEPEGEVGPPKINGEAQPWL |
| Q7Z5L9 | S455 | Sugiyama | IRF2BP2 | AGGSHASKDANQVHSTTRRNsNsPPsPssMNQRRLGPREVG |
| Q7Z5L9 | Y17 | Sugiyama | IRF2BP2 | ____MAAAVAVAAASRRQsCyLCDLPRMPWAMIWDFTEPVC |
| Q86UK7 | S851 | Sugiyama | ZNF598 | HTDFCNREKPLSTKSKKNKKsAWQATtQQAGLDCRVCPTCQ |
| Q86VQ1 | S223 | Sugiyama | GLCCI1 | QTPsCWAEEGAEKRSHQRsAsWGsADQLKEQIAKLRQQLQR |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8N201 | S495 | Sugiyama | INTS1 KIAA1440 UNQ1821/PRO3434 | KFLAMVFQDLLTNKDDYLRAsRALLREIIKQTKHEINFQAF |
| Q8N257 | S37 | Sugiyama | H2BC26 H2BU1 HIST3H2BB | KAVTKAQKKDGKKRKRGRKEsysIyVyKVLKQVHPDTGIss |
| Q8N684 | S166 | Sugiyama | CPSF7 | PGKVLNGEKVDVRPAtRQNLsQFEAQARKRECVRVPRGGIP |
| Q8NBA8 | S132 | Sugiyama | DTWD2 | PLLAACLPQDKCKVKIGRRFsEERDPELSTVCRKSGTLILY |
| Q8NBJ5 | S607 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | DRAKSQKMREQQALSREAKNsDVLQsPLDsAARDEL_____ |
| Q8ND56 | T384 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | DKTKsFFDNIsCDDNRERRPtWAEERRLNAETFGIPLRPNR |
| Q8NE71 | S105 | Sugiyama | ABCF1 ABC50 | KKDVDDDGEEKELMERLKKLsVPtsDEEDEVPAPKPRGGKK |
| Q8TCY9 | S447 | Sugiyama | URGCP KIAA1507 URG4 | FVKRIRAIVGNVLRAPCRRVsVEDMAHAARKLGLKVDEDCE |
| Q8TD19 | T333 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | REMEEKVTLLNAPTKRPRsstVtEAPIAVVTSRTSEVYVWG |
| Q8TD47 | T247 | Sugiyama | RPS4Y2 RPS4Y2P | VIGNGNKPWISLPRGKGIRLtIAEERDKRLAAKQSSG____ |
| Q8TEW0 | S958 | Sugiyama | PARD3 PAR3 PAR3A | VDDDDEGMEtLEEDTEESSRsGREsVstAsDQPsHsLERQM |
| Q8TF44 | S237 | Sugiyama | C2CD4C FAM148C KIAA1957 NLF3 | DTGSSAESSPFGSPLLSRSVsLLKGFAQDSQAKVSQLRHSV |
| Q8WUX9 | S417 | Sugiyama | CHMP7 | DLPDNPRNRHFtNsVPNPRIsDAELEAELEKLsLsEGGLVP |
| Q8WZ42 | S20761 | Sugiyama | TTN | GGSPIINYVVQKRDAERKSWsTVTTECsKTSFRVANLEEGK |
| Q8WZ42 | S20768 | Sugiyama | TTN | YVVQKRDAERKSWsTVTTECsKTSFRVANLEEGKSYFFRVF |
| Q92538 | S174 | Sugiyama | GBF1 KIAA0248 | NESVCEIMQSCFRICFEMRLsELLRKSAEHTLVDMVQLLFT |
| Q92945 | S193 | Sugiyama | KHSRP FUBP2 | DSGCKVQIsPDsGGLPERsVsLtGAPEsVQKAKMMLDDIVS |
| Q92945 | S333 | Sugiyama | KHSRP FUBP2 | DRNEyGsRIGGGIDVPVPRHsVGVVIGRSGEMIKKIQNDAG |
| Q969S3 | S38 | Sugiyama | ZNF622 ZPR9 | MQRAHYKTDWHRYNLRRKVAsMAPVTAEGFQERVRAQRAVA |
| Q96G46 | S236 | Sugiyama | DUS3L | QQLRKREVRFERAEQALRRFsQGPtPAAAVPEGTAAEGAPR |
| Q96JP5 | S85 | Sugiyama | ZFP91 ZNF757 FKSG11 | AAAVSRRRKAEYPRRRRssPsARPPDVPGQQPQAAKsPsPV |
| Q96P16 | S285 | Sugiyama | RPRD1A P15RS | YKRKLARVSLVRKELRSRIQsLPDLSRLPNVTGSHMHLPFA |
| Q96RS6 | S373 | Sugiyama | NUDCD1 CML66 | EGLTWPELVIGDKQGELIRDsAQCAAIAERLMHLtsEELNP |
| Q96RU3 | S497 | Sugiyama | FNBP1 FBP17 KIAA0554 | AWLAEVEGRLPARSEQARRQsGLyDSQNPPTVNNCAQDREs |
| Q99584 | S32 | Sugiyama | S100A13 | SIETVVTTFFTFARQEGRKDsLsVNEFKELVTQQLPHLLKD |
| Q9BQG0 | S1166 | Sugiyama | MYBBP1A P160 | RPKLEKKDAKEIPsAtQsPIsKKRKKKGFLPETKKRKKRKs |
| Q9BQG0 | S1186 | Sugiyama | MYBBP1A P160 | sKKRKKKGFLPETKKRKKRKsEDGtPAEDGtPAATGGsQPP |
| Q9BX95 | T114 | Sugiyama | SGPP1 SPP1 | AAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLFCF |
| Q9BXS5 | S305 | Sugiyama | AP1M1 CLTNM | KHSHSRIEYMIKAKSQFKRRstANNVEIHIPVPNDADsPKF |
| Q9BXS5 | T306 | Sugiyama | AP1M1 CLTNM | HSHSRIEYMIKAKSQFKRRstANNVEIHIPVPNDADsPKFK |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9C0C2 | S429 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | EEEAKGDAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAA |
| Q9H0B6 | S428 | Sugiyama | KLC2 | NKPIWMHAEEREESKDKRRDsAPyGEyGsWYKACKVDsPtV |
| Q9H2U1 | S268 | Sugiyama | DHX36 DDX36 KIAA1488 MLEL1 RHAU | YIERGKGSACRIVCTQPRRIsAISVAERVAAERAEsCGSGN |
| Q9H6H4 | S152 | Sugiyama | REEP4 C8orf20 PP432 | AAVQAATKSQGALAGRLRsFsMQDLRSISDAPAPAyHDPLy |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9H9A7 | S456 | Sugiyama | RMI1 C9orf76 | HSLNNKILNREVVNYVQKRNsQISNENDCNLQSCSLRSSEN |
| Q9HAU0 | S471 | Sugiyama | PLEKHA5 KIAA1686 PEPP2 | MARYPEGYRtLPRNSKTRPEsICSVtPsTHDKTLGPGAEEK |
| Q9NP61 | S367 | Sugiyama | ARFGAP3 ARFGAP1 | DsyFTSSSSYFDEPVELRsssFssWDDssDSyWKKETSKDT |
| Q9NQX3 | S280 | Sugiyama | GPHN GPH KIAA1385 | TAsLsttPsEsPRAQAtsRLstAsCPtPKVQSRCSsKENIL |
| Q9NQZ2 | S462 | Sugiyama | UTP3 CRLZ1 SAS10 | RAKIRRRGQVREVRKEEQRYsGELsGIRAGVKKSIKLK___ |
| Q9NVN8 | S513 | Sugiyama | GNL3L | PNRHQMGWAKRNVDHRPKsNsMVDVCsVDRRSVLQRIMETD |
| Q9NXH9 | S514 | Sugiyama | TRMT1 | ALWDIMRCWEKECPVKRERLsETsPAFRILsVEPRLQANFT |
| Q9NYF8 | S320 | Sugiyama | BCLAF1 BTF KIAA0164 | sPAKtIAPQNAPRDEsRGRssFyPDGGDQETAKtGKFLKRF |
| Q9NYV4 | S1053 | Sugiyama | CDK12 CRK7 CRKRS KIAA0904 | LPHWQDCHELWSKKRRRQRQsGVVVEEPPPSKTSRKETtsG |
| Q9UBK8 | S226 | Sugiyama | MTRR | VLKQNAVNSNQSNVVIEDFEsSLTRSVPPLSQASLNIPGLP |
| Q9UBP6 | S27 | Sugiyama | METTL1 C12orf1 | NVAGAEAPPPQKRYYRQRAHsNPMADHTLRYPVKPEEMDWS |
| Q9UGV2 | S327 | Sugiyama | NDRG3 | KYFLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsV |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UHD1 | S200 | Sugiyama | CHORDC1 CHP1 | SGVPIFHEGMKYWSCCRRKtsDFNtFLAQEGCtKGKHMWTK |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UKJ3 | S890 | Sugiyama | GPATCH8 GPATC8 KIAA0553 | YSSSSDASSDQSCYSRQRSYsDDSYSDYSDRSRRHSKRSHD |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9UL51 | S668 | SIGNOR | HCN2 BCNG2 | MRRAFETVAIDRLDRIGKKNsILLHKVQHDLNSGVFNNQEN |
| Q9ULL1 | S611 | Sugiyama | PLEKHG1 KIAA1209 | GQMESTETSSSGHRIVRRAssAGEsNtCPPEIGTSDRTREL |
| Q9UN37 | S430 | Sugiyama | VPS4A VPS4 | SLATTRPTVNADDLLKVKKFsEDFGQES_____________ |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9UQ35 | S1455 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | PsRRsRsGssPGLRDGsGtPsRHsLsGssPGMKDIPRtPSR |
| Q9UQ35 | S1539 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEs |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S1542 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDss |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ80 | S267 | Sugiyama | PA2G4 EBP1 | YKRDPSKQYGLKMKtSRAFFsEVERRFDAMPFtLRAFEDEK |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2I7 | S307 | Sugiyama | PIKFYVE KIAA0981 PIP5K3 | TRLVSVQEDAGKsPARNRsAsItNLsLDRsGsPMVPSYEts |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.914979e-10 | 9.718 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 5.780704e-08 | 7.238 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 2.816236e-07 | 6.550 | 1 | 0 |
| Axon guidance | R-HSA-422475 | 1.053449e-06 | 5.977 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 1.065273e-06 | 5.973 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.679816e-06 | 5.775 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.087015e-06 | 5.680 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.342469e-06 | 5.476 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 5.185433e-06 | 5.285 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 5.644164e-06 | 5.248 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 8.800065e-06 | 5.056 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 9.824177e-06 | 5.008 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 1.108232e-05 | 4.955 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 1.108232e-05 | 4.955 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.356264e-05 | 4.868 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.399998e-05 | 4.854 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.426629e-05 | 4.846 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.400708e-05 | 4.854 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.683334e-05 | 4.774 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 2.099570e-05 | 4.678 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.308624e-05 | 4.637 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.564279e-05 | 4.591 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.658359e-05 | 4.437 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 4.015137e-05 | 4.396 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 5.588514e-05 | 4.253 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 5.750945e-05 | 4.240 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 7.500550e-05 | 4.125 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.826588e-05 | 4.106 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 7.866736e-05 | 4.104 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.714000e-05 | 4.013 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.016893e-04 | 3.993 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.276970e-04 | 3.894 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.329646e-04 | 3.876 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.399925e-04 | 3.854 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.906842e-04 | 3.720 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.010975e-04 | 3.697 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.131767e-04 | 3.671 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 2.276197e-04 | 3.643 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 2.278607e-04 | 3.642 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 2.597076e-04 | 3.586 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.867383e-04 | 3.413 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 4.202327e-04 | 3.377 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.610164e-04 | 3.336 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.757133e-04 | 3.323 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.471149e-04 | 3.262 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 5.684422e-04 | 3.245 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.798574e-04 | 3.237 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 6.298418e-04 | 3.201 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.418044e-04 | 3.193 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.096150e-04 | 3.149 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 9.440084e-04 | 3.025 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 9.440084e-04 | 3.025 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 9.440084e-04 | 3.025 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 9.440084e-04 | 3.025 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 9.441216e-04 | 3.025 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.441216e-04 | 3.025 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.206702e-03 | 2.918 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.248237e-03 | 2.904 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.305065e-03 | 2.884 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.256185e-03 | 2.901 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.773567e-03 | 2.751 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.907451e-03 | 2.720 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.952017e-03 | 2.710 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.200158e-03 | 2.658 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 2.312013e-03 | 2.636 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.305711e-03 | 2.637 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.286459e-03 | 2.641 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.286459e-03 | 2.641 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.320999e-03 | 2.634 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.368225e-03 | 2.626 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.609760e-03 | 2.583 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.578365e-03 | 2.589 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.820249e-03 | 2.550 | 1 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.167204e-03 | 2.499 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.090690e-03 | 2.510 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.280591e-03 | 2.484 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.301999e-03 | 2.481 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.495645e-03 | 2.456 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.342465e-03 | 2.476 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.043364e-03 | 2.393 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.260531e-03 | 2.371 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 4.280729e-03 | 2.368 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 4.486829e-03 | 2.348 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 4.527811e-03 | 2.344 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 4.627285e-03 | 2.335 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.671669e-03 | 2.331 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 4.764960e-03 | 2.322 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 4.925544e-03 | 2.308 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 5.578047e-03 | 2.254 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 5.377577e-03 | 2.269 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.713940e-03 | 2.243 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 5.831498e-03 | 2.234 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.128907e-03 | 2.213 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.128907e-03 | 2.213 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 6.282488e-03 | 2.202 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 6.252754e-03 | 2.204 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.938306e-03 | 2.226 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.355469e-03 | 2.197 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 6.364240e-03 | 2.196 | 1 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 6.913760e-03 | 2.160 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 7.036100e-03 | 2.153 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 7.351029e-03 | 2.134 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 7.520148e-03 | 2.124 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.057425e-03 | 2.151 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 8.259841e-03 | 2.083 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 8.274393e-03 | 2.082 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.968864e-03 | 2.047 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.006134e-02 | 1.997 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 9.854495e-03 | 2.006 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.007007e-02 | 1.997 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.625251e-03 | 2.017 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 9.678390e-03 | 2.014 | 1 | 0 |
| TRP channels | R-HSA-3295583 | 1.025426e-02 | 1.989 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.025426e-02 | 1.989 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.105938e-02 | 1.956 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.139764e-02 | 1.943 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.149620e-02 | 1.939 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.156787e-02 | 1.937 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.203764e-02 | 1.919 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.274339e-02 | 1.895 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 1.296275e-02 | 1.887 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.317683e-02 | 1.880 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.317683e-02 | 1.880 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.341223e-02 | 1.872 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.341223e-02 | 1.872 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.351865e-02 | 1.869 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.383933e-02 | 1.859 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.464254e-02 | 1.834 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.447385e-02 | 1.839 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.432268e-02 | 1.844 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.468915e-02 | 1.833 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.468915e-02 | 1.833 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 1.482208e-02 | 1.829 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 1.489255e-02 | 1.827 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.501019e-02 | 1.824 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.624841e-02 | 1.789 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.693006e-02 | 1.771 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 1.703331e-02 | 1.769 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.717160e-02 | 1.765 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.939222e-02 | 1.712 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.939222e-02 | 1.712 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.939222e-02 | 1.712 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.939222e-02 | 1.712 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.939222e-02 | 1.712 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 1.793222e-02 | 1.746 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.813497e-02 | 1.741 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.870378e-02 | 1.728 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.982273e-02 | 1.703 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.136302e-02 | 1.670 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.031054e-02 | 1.692 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.070591e-02 | 1.684 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 2.171185e-02 | 1.663 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 1.993628e-02 | 1.700 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.070591e-02 | 1.684 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.189542e-02 | 1.660 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.132660e-02 | 1.671 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 2.031054e-02 | 1.692 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.255339e-02 | 1.647 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.365201e-02 | 1.626 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.366118e-02 | 1.626 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.366118e-02 | 1.626 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.366118e-02 | 1.626 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.499050e-02 | 1.602 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.509526e-02 | 1.600 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.835657e-02 | 1.547 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.835657e-02 | 1.547 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.835657e-02 | 1.547 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 2.835657e-02 | 1.547 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.835657e-02 | 1.547 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.835657e-02 | 1.547 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.794642e-02 | 1.554 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 2.737711e-02 | 1.563 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 2.737711e-02 | 1.563 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 2.811926e-02 | 1.551 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.672746e-02 | 1.573 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.608430e-02 | 1.584 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.672746e-02 | 1.573 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 2.589572e-02 | 1.587 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 2.870333e-02 | 1.542 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 2.917514e-02 | 1.535 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.258817e-02 | 1.487 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.258817e-02 | 1.487 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 3.080979e-02 | 1.511 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 3.080979e-02 | 1.511 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.385113e-02 | 1.470 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 3.150694e-02 | 1.502 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.258817e-02 | 1.487 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 3.249208e-02 | 1.488 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 3.385113e-02 | 1.470 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.112207e-02 | 1.507 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.155971e-02 | 1.501 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.155971e-02 | 1.501 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 3.133507e-02 | 1.504 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 3.564705e-02 | 1.448 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.584905e-02 | 1.446 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 3.606132e-02 | 1.443 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 3.610037e-02 | 1.442 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 3.751831e-02 | 1.426 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 3.751831e-02 | 1.426 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 3.751831e-02 | 1.426 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 3.751831e-02 | 1.426 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 3.751831e-02 | 1.426 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 3.761399e-02 | 1.425 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.807909e-02 | 1.419 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.956591e-02 | 1.403 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.956591e-02 | 1.403 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.958308e-02 | 1.402 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.961579e-02 | 1.402 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.961579e-02 | 1.402 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.961579e-02 | 1.402 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 4.277130e-02 | 1.369 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.277130e-02 | 1.369 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.277130e-02 | 1.369 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.715889e-02 | 1.326 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.715889e-02 | 1.326 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 4.651526e-02 | 1.332 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.651526e-02 | 1.332 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 4.715889e-02 | 1.326 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 4.651526e-02 | 1.332 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.433072e-02 | 1.353 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.433072e-02 | 1.353 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.433072e-02 | 1.353 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 4.679141e-02 | 1.330 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 4.277130e-02 | 1.369 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.479360e-02 | 1.349 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.764119e-02 | 1.322 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.782315e-02 | 1.320 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 4.782315e-02 | 1.320 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.782315e-02 | 1.320 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 4.823963e-02 | 1.317 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 4.843195e-02 | 1.315 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.847535e-02 | 1.314 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 4.852784e-02 | 1.314 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 4.852784e-02 | 1.314 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 4.934375e-02 | 1.307 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.996519e-02 | 1.301 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.049966e-02 | 1.297 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.135273e-02 | 1.289 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 5.177166e-02 | 1.286 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.225344e-02 | 1.282 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.225344e-02 | 1.282 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.225344e-02 | 1.282 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 5.244615e-02 | 1.280 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.244615e-02 | 1.280 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 5.278667e-02 | 1.277 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 5.281783e-02 | 1.277 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.405399e-02 | 1.267 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 5.866012e-02 | 1.232 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 5.866012e-02 | 1.232 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.415641e-02 | 1.193 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 6.415641e-02 | 1.193 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 6.415641e-02 | 1.193 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.969124e-02 | 1.224 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 5.675478e-02 | 1.246 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.675478e-02 | 1.246 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 5.886387e-02 | 1.230 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 5.825243e-02 | 1.235 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 6.371656e-02 | 1.196 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.964249e-02 | 1.224 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 5.675478e-02 | 1.246 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 6.415641e-02 | 1.193 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.337073e-02 | 1.198 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 6.480155e-02 | 1.188 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 6.577888e-02 | 1.182 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 6.577888e-02 | 1.182 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.577888e-02 | 1.182 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.577888e-02 | 1.182 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.588629e-02 | 1.181 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.654261e-02 | 1.177 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 6.799421e-02 | 1.168 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 6.944822e-02 | 1.158 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.944822e-02 | 1.158 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 6.944822e-02 | 1.158 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.966871e-02 | 1.157 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.978654e-02 | 1.156 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 6.978654e-02 | 1.156 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 7.053840e-02 | 1.152 | 0 | 0 |
| S Phase | R-HSA-69242 | 7.060529e-02 | 1.151 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 7.192189e-02 | 1.143 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.210585e-02 | 1.142 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 8.734208e-02 | 1.059 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 8.734208e-02 | 1.059 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 8.734208e-02 | 1.059 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 8.734208e-02 | 1.059 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 7.289179e-02 | 1.137 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.289179e-02 | 1.137 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 7.580213e-02 | 1.120 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 8.720065e-02 | 1.059 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.088560e-02 | 1.092 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 8.214278e-02 | 1.085 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 7.289179e-02 | 1.137 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 8.214278e-02 | 1.085 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.297489e-02 | 1.137 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.453960e-02 | 1.073 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.403577e-02 | 1.076 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 7.297489e-02 | 1.137 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 7.297489e-02 | 1.137 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.449993e-02 | 1.073 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.641026e-02 | 1.117 | 1 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.289179e-02 | 1.137 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.088560e-02 | 1.092 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.145519e-02 | 1.089 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.740242e-02 | 1.111 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 7.887546e-02 | 1.103 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.289179e-02 | 1.137 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 7.891369e-02 | 1.103 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 8.779450e-02 | 1.057 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 8.779450e-02 | 1.057 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.779450e-02 | 1.057 | 1 | 1 |
| HDL assembly | R-HSA-8963896 | 8.779450e-02 | 1.057 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.779450e-02 | 1.057 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 8.866503e-02 | 1.052 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 9.047047e-02 | 1.043 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 9.109540e-02 | 1.041 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 9.109540e-02 | 1.041 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 9.109540e-02 | 1.041 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 9.597335e-02 | 1.018 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 9.597335e-02 | 1.018 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 9.651437e-02 | 1.015 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.741420e-02 | 1.011 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.010279e-01 | 0.996 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.015001e-01 | 0.994 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.040532e-01 | 0.983 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 1.040532e-01 | 0.983 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.044941e-01 | 0.981 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.058752e-01 | 0.975 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.065861e-01 | 0.972 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 1.216687e-01 | 0.915 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 1.216687e-01 | 0.915 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 1.216687e-01 | 0.915 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 1.216687e-01 | 0.915 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 1.216687e-01 | 0.915 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 1.216687e-01 | 0.915 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.216687e-01 | 0.915 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 1.216687e-01 | 0.915 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 1.216687e-01 | 0.915 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 1.216687e-01 | 0.915 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 1.381436e-01 | 0.860 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.381436e-01 | 0.860 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.331644e-01 | 0.876 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.216834e-01 | 0.915 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.393939e-01 | 0.856 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.393939e-01 | 0.856 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.179958e-01 | 0.928 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.390973e-01 | 0.857 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.393939e-01 | 0.856 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.345602e-01 | 0.871 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.146958e-01 | 0.940 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.258926e-01 | 0.900 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.258788e-01 | 0.900 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.284814e-01 | 0.891 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.266885e-01 | 0.897 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.266885e-01 | 0.897 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.216834e-01 | 0.915 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.268185e-01 | 0.897 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.258788e-01 | 0.900 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 1.393939e-01 | 0.856 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.290333e-01 | 0.889 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.315495e-01 | 0.881 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.203558e-01 | 0.920 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.265665e-01 | 0.898 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 1.127305e-01 | 0.948 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.380013e-01 | 0.860 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.121200e-01 | 0.950 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.216834e-01 | 0.915 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.393939e-01 | 0.856 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 1.127305e-01 | 0.948 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.238320e-01 | 0.907 | 0 | 0 |
| Depurination | R-HSA-73927 | 1.361728e-01 | 0.866 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.271267e-01 | 0.896 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 1.400078e-01 | 0.854 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.406003e-01 | 0.852 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.418228e-01 | 0.848 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 1.422099e-01 | 0.847 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.422099e-01 | 0.847 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 1.422099e-01 | 0.847 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.422099e-01 | 0.847 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 1.425692e-01 | 0.846 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.438173e-01 | 0.842 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 1.447300e-01 | 0.839 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 1.473379e-01 | 0.832 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 1.473742e-01 | 0.832 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.285403e-01 | 0.641 | 0 | 0 |
| Defective ACTH causes obesity and POMCD | R-HSA-5579031 | 2.285403e-01 | 0.641 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.285403e-01 | 0.641 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.285403e-01 | 0.641 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.285403e-01 | 0.641 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.285403e-01 | 0.641 | 0 | 0 |
| Defective SLC26A4 causes Pendred syndrome (PDS) | R-HSA-5619046 | 2.285403e-01 | 0.641 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.834378e-01 | 0.737 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.834378e-01 | 0.737 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.834378e-01 | 0.737 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.834378e-01 | 0.737 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 1.834378e-01 | 0.737 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 1.834378e-01 | 0.737 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 3.224137e-01 | 0.492 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 3.224137e-01 | 0.492 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 3.224137e-01 | 0.492 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 3.224137e-01 | 0.492 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.224137e-01 | 0.492 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.224137e-01 | 0.492 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 3.224137e-01 | 0.492 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.224137e-01 | 0.492 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 3.224137e-01 | 0.492 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 3.224137e-01 | 0.492 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.224137e-01 | 0.492 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.224137e-01 | 0.492 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.224137e-01 | 0.492 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.224137e-01 | 0.492 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 3.224137e-01 | 0.492 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 3.224137e-01 | 0.492 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 3.224137e-01 | 0.492 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.224137e-01 | 0.492 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.224137e-01 | 0.492 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 3.224137e-01 | 0.492 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 2.304725e-01 | 0.637 | 0 | 0 |
| IRS activation | R-HSA-74713 | 2.304725e-01 | 0.637 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.304725e-01 | 0.637 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.730167e-01 | 0.762 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 1.566908e-01 | 0.805 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 1.566908e-01 | 0.805 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 2.054798e-01 | 0.687 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.054798e-01 | 0.687 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 2.781542e-01 | 0.556 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.781542e-01 | 0.556 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.048691e-01 | 0.393 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.048691e-01 | 0.393 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.048691e-01 | 0.393 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 4.048691e-01 | 0.393 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 4.048691e-01 | 0.393 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.048691e-01 | 0.393 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.048691e-01 | 0.393 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.048691e-01 | 0.393 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.048691e-01 | 0.393 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.048691e-01 | 0.393 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 4.048691e-01 | 0.393 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.048691e-01 | 0.393 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.048691e-01 | 0.393 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 4.048691e-01 | 0.393 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.048691e-01 | 0.393 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.048691e-01 | 0.393 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.048691e-01 | 0.393 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.048691e-01 | 0.393 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 4.048691e-01 | 0.393 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 4.048691e-01 | 0.393 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.048691e-01 | 0.393 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 4.048691e-01 | 0.393 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.048691e-01 | 0.393 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.816209e-01 | 0.741 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.816209e-01 | 0.741 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 2.391724e-01 | 0.621 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 2.391724e-01 | 0.621 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 2.391724e-01 | 0.621 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.391724e-01 | 0.621 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 2.391724e-01 | 0.621 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.256296e-01 | 0.487 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 3.256296e-01 | 0.487 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.256296e-01 | 0.487 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 3.256296e-01 | 0.487 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 3.256296e-01 | 0.487 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.256296e-01 | 0.487 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 2.736949e-01 | 0.563 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 2.736949e-01 | 0.563 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 2.348638e-01 | 0.629 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 2.040327e-01 | 0.690 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.739613e-01 | 0.760 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.980418e-01 | 0.703 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 2.270132e-01 | 0.644 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 2.270132e-01 | 0.644 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 2.270132e-01 | 0.644 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 2.270132e-01 | 0.644 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 2.627577e-01 | 0.580 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 2.627577e-01 | 0.580 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.086800e-01 | 0.510 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.086800e-01 | 0.510 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.086800e-01 | 0.510 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 3.722434e-01 | 0.429 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.722434e-01 | 0.429 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.722434e-01 | 0.429 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 3.722434e-01 | 0.429 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.722434e-01 | 0.429 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.722434e-01 | 0.429 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.722434e-01 | 0.429 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.722434e-01 | 0.429 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.772948e-01 | 0.321 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.772948e-01 | 0.321 | 0 | 0 |
| Defective ABCA1 causes TGD | R-HSA-5682113 | 4.772948e-01 | 0.321 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.772948e-01 | 0.321 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.772948e-01 | 0.321 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 4.772948e-01 | 0.321 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.772948e-01 | 0.321 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.772948e-01 | 0.321 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 1.491236e-01 | 0.826 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.491236e-01 | 0.826 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.911510e-01 | 0.719 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.911510e-01 | 0.719 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.507032e-01 | 0.601 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 2.912269e-01 | 0.536 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 2.089901e-01 | 0.680 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 3.437972e-01 | 0.464 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 3.437972e-01 | 0.464 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 2.274201e-01 | 0.643 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.913958e-01 | 0.718 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.913958e-01 | 0.718 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 1.628463e-01 | 0.788 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.600624e-01 | 0.585 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.600624e-01 | 0.585 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 3.200759e-01 | 0.495 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 4.175026e-01 | 0.379 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 4.175026e-01 | 0.379 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 4.175026e-01 | 0.379 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 4.175026e-01 | 0.379 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.175026e-01 | 0.379 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.175026e-01 | 0.379 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 1.752246e-01 | 0.756 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.065309e-01 | 0.685 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.817950e-01 | 0.550 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 3.787537e-01 | 0.422 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 3.787537e-01 | 0.422 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 3.491203e-01 | 0.457 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 3.247552e-01 | 0.488 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.039101e-01 | 0.517 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.039101e-01 | 0.517 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.948307e-01 | 0.710 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.856281e-01 | 0.544 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.856281e-01 | 0.544 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 2.566461e-01 | 0.591 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.132947e-01 | 0.384 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 4.132947e-01 | 0.384 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 5.409101e-01 | 0.267 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 5.409101e-01 | 0.267 | 0 | 0 |
| MPS VI - Maroteaux-Lamy syndrome | R-HSA-2206285 | 5.409101e-01 | 0.267 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 5.409101e-01 | 0.267 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.409101e-01 | 0.267 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.409101e-01 | 0.267 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.724335e-01 | 0.565 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.062637e-01 | 0.514 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 3.753769e-01 | 0.426 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 4.071219e-01 | 0.390 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.472024e-01 | 0.349 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.472024e-01 | 0.349 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.472024e-01 | 0.349 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.711446e-01 | 0.567 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 2.112221e-01 | 0.675 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 2.112221e-01 | 0.675 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.546085e-01 | 0.811 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 5.026231e-01 | 0.299 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 5.026231e-01 | 0.299 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.884630e-01 | 0.411 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.259435e-01 | 0.371 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.259435e-01 | 0.371 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 3.282997e-01 | 0.484 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 3.827191e-01 | 0.417 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 3.827191e-01 | 0.417 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 3.772255e-01 | 0.423 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 4.172217e-01 | 0.380 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 4.802936e-01 | 0.318 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 4.802936e-01 | 0.318 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.719641e-01 | 0.429 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.719641e-01 | 0.429 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.093263e-01 | 0.388 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.093263e-01 | 0.388 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.093263e-01 | 0.388 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 3.350775e-01 | 0.475 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 4.640277e-01 | 0.333 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 4.509558e-01 | 0.346 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 4.509558e-01 | 0.346 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 4.509558e-01 | 0.346 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.483938e-01 | 0.458 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.483938e-01 | 0.458 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.155815e-01 | 0.381 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 4.756691e-01 | 0.323 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.124182e-01 | 0.290 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.124182e-01 | 0.290 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 5.124182e-01 | 0.290 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.124182e-01 | 0.290 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.124182e-01 | 0.290 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 4.845797e-01 | 0.315 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.845797e-01 | 0.315 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 5.000050e-01 | 0.301 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 5.000050e-01 | 0.301 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 4.790400e-01 | 0.320 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 5.065198e-01 | 0.295 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.434558e-01 | 0.265 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 5.238929e-01 | 0.281 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 5.238929e-01 | 0.281 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.417467e-01 | 0.355 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.900325e-01 | 0.310 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 5.452817e-01 | 0.263 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.452817e-01 | 0.263 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.792784e-01 | 0.237 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 5.792784e-01 | 0.237 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.792784e-01 | 0.237 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 5.092216e-01 | 0.293 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 5.733132e-01 | 0.242 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.513266e-01 | 0.259 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.533180e-01 | 0.257 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.571701e-01 | 0.254 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.700839e-01 | 0.244 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.700550e-01 | 0.244 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.721026e-01 | 0.243 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 5.742130e-01 | 0.241 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.887627e-01 | 0.230 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.887627e-01 | 0.230 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 2.444154e-01 | 0.612 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.060581e-01 | 0.514 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 2.112221e-01 | 0.675 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 1.773260e-01 | 0.751 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 4.845797e-01 | 0.315 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.489381e-01 | 0.457 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 5.700839e-01 | 0.244 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.168921e-01 | 0.380 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.373212e-01 | 0.270 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 5.700839e-01 | 0.244 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 5.922862e-01 | 0.227 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 2.221337e-01 | 0.653 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 2.658035e-01 | 0.575 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.818380e-01 | 0.550 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.000050e-01 | 0.301 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.463791e-01 | 0.608 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 3.247552e-01 | 0.488 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.468458e-01 | 0.460 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.357778e-01 | 0.361 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 4.509558e-01 | 0.346 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 5.032900e-01 | 0.298 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.118997e-01 | 0.674 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 3.437972e-01 | 0.464 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.274201e-01 | 0.643 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 2.545962e-01 | 0.594 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 2.897073e-01 | 0.538 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.728333e-01 | 0.762 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.508725e-01 | 0.346 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.451627e-01 | 0.611 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 2.725899e-01 | 0.564 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.676857e-01 | 0.330 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 2.193853e-01 | 0.659 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 3.057872e-01 | 0.515 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 4.472024e-01 | 0.349 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.163945e-01 | 0.380 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.032900e-01 | 0.298 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 2.839079e-01 | 0.547 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 3.890324e-01 | 0.410 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.472024e-01 | 0.349 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.496895e-01 | 0.347 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.529114e-01 | 0.257 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.054798e-01 | 0.687 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.391724e-01 | 0.621 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.012808e-01 | 0.521 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 3.165588e-01 | 0.500 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.720156e-01 | 0.565 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 3.491203e-01 | 0.457 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.023514e-01 | 0.694 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 4.768033e-01 | 0.322 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 2.180983e-01 | 0.661 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 2.054798e-01 | 0.687 | 0 | 0 |
| Formation of lateral plate mesoderm | R-HSA-9758920 | 2.781542e-01 | 0.556 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.722434e-01 | 0.429 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 2.337804e-01 | 0.631 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 3.787537e-01 | 0.422 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.876424e-01 | 0.541 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 3.716809e-01 | 0.430 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 4.472024e-01 | 0.349 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.026231e-01 | 0.299 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.620623e-01 | 0.441 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.360434e-01 | 0.474 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 4.917583e-01 | 0.308 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 4.480900e-01 | 0.349 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 4.480900e-01 | 0.349 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 4.906667e-01 | 0.309 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 5.700839e-01 | 0.244 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.451627e-01 | 0.611 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.684688e-01 | 0.773 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 3.282997e-01 | 0.484 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.733132e-01 | 0.242 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.485138e-01 | 0.458 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.887627e-01 | 0.230 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.141449e-01 | 0.289 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 1.566908e-01 | 0.805 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.054798e-01 | 0.687 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.818889e-01 | 0.740 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 2.348638e-01 | 0.629 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 3.086800e-01 | 0.510 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.175026e-01 | 0.379 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.610467e-01 | 0.336 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.409101e-01 | 0.267 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.262148e-01 | 0.486 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 2.332546e-01 | 0.632 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.165588e-01 | 0.500 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.253894e-01 | 0.647 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.792784e-01 | 0.237 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.263301e-01 | 0.279 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.461878e-01 | 0.263 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 2.391724e-01 | 0.621 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 2.391724e-01 | 0.621 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.437972e-01 | 0.464 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.913958e-01 | 0.718 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 3.039101e-01 | 0.517 | 1 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 4.259435e-01 | 0.371 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 2.693208e-01 | 0.570 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.997843e-01 | 0.523 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.232747e-01 | 0.373 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 3.185368e-01 | 0.497 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.842297e-01 | 0.735 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 2.427570e-01 | 0.615 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 3.771390e-01 | 0.423 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 1.834378e-01 | 0.737 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 3.256296e-01 | 0.487 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 2.180983e-01 | 0.661 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.912269e-01 | 0.536 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.175026e-01 | 0.379 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.463791e-01 | 0.608 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.795919e-01 | 0.746 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.795919e-01 | 0.746 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.795919e-01 | 0.746 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.795919e-01 | 0.746 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.263199e-01 | 0.486 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 3.781883e-01 | 0.422 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 4.610467e-01 | 0.336 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 4.093263e-01 | 0.388 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.124182e-01 | 0.290 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.420658e-01 | 0.266 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.900325e-01 | 0.310 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.281103e-01 | 0.277 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.700839e-01 | 0.244 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.917601e-01 | 0.228 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.865076e-01 | 0.543 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.845797e-01 | 0.315 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.463791e-01 | 0.608 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 4.172217e-01 | 0.380 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.348638e-01 | 0.629 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.964148e-01 | 0.304 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 2.870062e-01 | 0.542 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.251331e-01 | 0.488 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 4.093263e-01 | 0.388 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.620623e-01 | 0.441 | 1 | 1 |
| Platelet calcium homeostasis | R-HSA-418360 | 1.739613e-01 | 0.760 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.839615e-01 | 0.735 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.370312e-01 | 0.270 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.235583e-01 | 0.651 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.834378e-01 | 0.737 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 3.256296e-01 | 0.487 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.040327e-01 | 0.690 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.437972e-01 | 0.464 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.437972e-01 | 0.464 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.437972e-01 | 0.464 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 2.166612e-01 | 0.664 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.175026e-01 | 0.379 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 2.463791e-01 | 0.608 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 5.026231e-01 | 0.299 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.700839e-01 | 0.244 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 3.315897e-01 | 0.479 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.234474e-01 | 0.490 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.234474e-01 | 0.490 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.531569e-01 | 0.815 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 2.087711e-01 | 0.680 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.796744e-01 | 0.237 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.550562e-01 | 0.810 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 4.407359e-01 | 0.356 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.704030e-01 | 0.328 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.709197e-01 | 0.243 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.692667e-01 | 0.771 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.467660e-01 | 0.460 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 3.086800e-01 | 0.510 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 2.912269e-01 | 0.536 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.453472e-01 | 0.610 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.761847e-01 | 0.425 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.000050e-01 | 0.301 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.712053e-01 | 0.243 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.000398e-01 | 0.699 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.641138e-01 | 0.785 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 1.490846e-01 | 0.827 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 3.722434e-01 | 0.429 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.610467e-01 | 0.336 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.686072e-01 | 0.773 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.452817e-01 | 0.263 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.288616e-01 | 0.640 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.704030e-01 | 0.328 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.982647e-01 | 0.703 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 4.235474e-01 | 0.373 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 2.285403e-01 | 0.641 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 1.834378e-01 | 0.737 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.224137e-01 | 0.492 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.054798e-01 | 0.687 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.054798e-01 | 0.687 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 2.781542e-01 | 0.556 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.048691e-01 | 0.393 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.048691e-01 | 0.393 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.818889e-01 | 0.740 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.818889e-01 | 0.740 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 1.818889e-01 | 0.740 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.601996e-01 | 0.795 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.601996e-01 | 0.795 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 2.736949e-01 | 0.563 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 2.040327e-01 | 0.690 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.270132e-01 | 0.644 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 3.722434e-01 | 0.429 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.772948e-01 | 0.321 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.772948e-01 | 0.321 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.437972e-01 | 0.464 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 1.831180e-01 | 0.737 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.200759e-01 | 0.495 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 3.787537e-01 | 0.422 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 3.781883e-01 | 0.422 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.610467e-01 | 0.336 | 0 | 0 |
| Transmission across Electrical Synapses | R-HSA-112307 | 5.409101e-01 | 0.267 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 5.409101e-01 | 0.267 | 0 | 0 |
| Electric Transmission Across Gap Junctions | R-HSA-112303 | 5.409101e-01 | 0.267 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 5.026231e-01 | 0.299 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 5.026231e-01 | 0.299 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 5.026231e-01 | 0.299 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 4.509558e-01 | 0.346 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 4.398697e-01 | 0.357 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.902980e-01 | 0.229 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.513500e-01 | 0.600 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 1.932750e-01 | 0.714 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.496895e-01 | 0.347 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 4.007190e-01 | 0.397 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.262148e-01 | 0.486 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.234474e-01 | 0.490 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 3.034088e-01 | 0.518 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 5.124182e-01 | 0.290 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 5.731184e-01 | 0.242 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.720156e-01 | 0.565 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 5.700550e-01 | 0.244 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.700550e-01 | 0.244 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.232747e-01 | 0.373 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.724335e-01 | 0.565 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 3.489381e-01 | 0.457 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 5.123074e-01 | 0.290 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.713789e-01 | 0.566 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.665196e-01 | 0.436 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 4.403838e-01 | 0.356 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 4.403838e-01 | 0.356 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 4.920849e-01 | 0.308 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.500749e-01 | 0.456 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.391724e-01 | 0.621 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 4.175026e-01 | 0.379 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.997001e-01 | 0.523 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 5.124182e-01 | 0.290 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 5.676548e-01 | 0.246 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 2.557858e-01 | 0.592 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.491203e-01 | 0.457 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 2.381680e-01 | 0.623 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 2.304725e-01 | 0.637 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.816209e-01 | 0.741 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.256296e-01 | 0.487 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 2.997001e-01 | 0.523 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 3.787537e-01 | 0.422 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 4.610467e-01 | 0.336 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.610467e-01 | 0.336 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 4.610467e-01 | 0.336 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 4.610467e-01 | 0.336 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.451627e-01 | 0.611 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.472024e-01 | 0.349 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 3.634113e-01 | 0.440 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.250189e-01 | 0.488 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 5.420658e-01 | 0.266 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 5.420658e-01 | 0.266 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.188710e-01 | 0.285 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.318046e-01 | 0.274 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.922862e-01 | 0.227 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 5.903283e-01 | 0.229 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.795919e-01 | 0.746 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.286016e-01 | 0.483 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 3.753769e-01 | 0.426 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.007190e-01 | 0.397 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.658035e-01 | 0.575 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.782144e-01 | 0.422 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.818889e-01 | 0.740 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.513500e-01 | 0.600 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.918248e-01 | 0.308 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 5.660093e-01 | 0.247 | 1 | 0 |
| Glucose metabolism | R-HSA-70326 | 2.625459e-01 | 0.581 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 5.434558e-01 | 0.265 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 4.574431e-01 | 0.340 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.092410e-01 | 0.293 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.782144e-01 | 0.422 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.969221e-01 | 0.401 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.781542e-01 | 0.556 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 4.048691e-01 | 0.393 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 2.391724e-01 | 0.621 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 4.772948e-01 | 0.321 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.065309e-01 | 0.685 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.491203e-01 | 0.457 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 4.610467e-01 | 0.336 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.409101e-01 | 0.267 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.944678e-01 | 0.404 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.357778e-01 | 0.361 | 0 | 0 |
| LTC4-CYSLTR mediated IL4 production | R-HSA-9664535 | 5.026231e-01 | 0.299 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.026231e-01 | 0.299 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 5.026231e-01 | 0.299 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 4.802936e-01 | 0.318 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 4.802936e-01 | 0.318 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 5.420658e-01 | 0.266 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.452817e-01 | 0.263 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.792784e-01 | 0.237 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.493030e-01 | 0.260 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.768639e-01 | 0.239 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 4.020739e-01 | 0.396 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.509558e-01 | 0.346 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 1.970020e-01 | 0.706 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 3.263199e-01 | 0.486 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 3.500193e-01 | 0.456 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.003883e-01 | 0.522 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 4.407359e-01 | 0.356 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 2.454275e-01 | 0.610 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.491236e-01 | 0.826 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.730167e-01 | 0.762 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.085834e-01 | 0.511 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 3.256296e-01 | 0.487 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.772948e-01 | 0.321 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.948307e-01 | 0.710 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.420658e-01 | 0.266 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.778756e-01 | 0.423 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.472024e-01 | 0.349 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.607053e-01 | 0.794 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 3.722434e-01 | 0.429 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.722434e-01 | 0.429 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 4.175026e-01 | 0.379 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 5.409101e-01 | 0.267 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.409101e-01 | 0.267 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.213750e-01 | 0.493 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 5.124182e-01 | 0.290 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.188710e-01 | 0.285 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 2.253515e-01 | 0.647 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.880360e-01 | 0.726 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.781542e-01 | 0.556 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.472024e-01 | 0.349 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.172217e-01 | 0.380 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.420658e-01 | 0.266 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.777293e-01 | 0.321 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.491203e-01 | 0.457 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.787537e-01 | 0.422 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.922862e-01 | 0.227 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 4.604451e-01 | 0.337 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.640277e-01 | 0.333 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.733132e-01 | 0.242 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.026231e-01 | 0.299 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 5.733132e-01 | 0.242 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 5.957272e-01 | 0.225 | 0 | 0 |
| Activation of AMPA receptors | R-HSA-399710 | 5.967865e-01 | 0.224 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 5.967865e-01 | 0.224 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.967865e-01 | 0.224 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.967865e-01 | 0.224 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 5.967865e-01 | 0.224 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.967865e-01 | 0.224 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.967865e-01 | 0.224 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.967865e-01 | 0.224 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.967865e-01 | 0.224 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.967865e-01 | 0.224 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.967865e-01 | 0.224 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.967865e-01 | 0.224 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.967865e-01 | 0.224 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.967865e-01 | 0.224 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 5.967865e-01 | 0.224 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 6.019217e-01 | 0.220 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.019217e-01 | 0.220 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.019217e-01 | 0.220 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 6.039013e-01 | 0.219 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 6.064357e-01 | 0.217 | 1 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 6.076108e-01 | 0.216 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 6.100900e-01 | 0.215 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.138382e-01 | 0.212 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.138382e-01 | 0.212 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.138382e-01 | 0.212 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.138382e-01 | 0.212 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.138382e-01 | 0.212 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 6.138382e-01 | 0.212 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.142194e-01 | 0.212 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.142194e-01 | 0.212 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.142194e-01 | 0.212 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.142194e-01 | 0.212 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.142194e-01 | 0.212 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 6.142194e-01 | 0.212 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 6.142194e-01 | 0.212 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 6.142194e-01 | 0.212 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 6.142194e-01 | 0.212 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 6.142194e-01 | 0.212 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 6.142194e-01 | 0.212 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 6.168724e-01 | 0.210 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 6.168724e-01 | 0.210 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.170060e-01 | 0.210 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 6.172097e-01 | 0.210 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 6.193909e-01 | 0.208 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 6.196583e-01 | 0.208 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.196583e-01 | 0.208 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 6.199298e-01 | 0.208 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.227942e-01 | 0.206 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 6.227942e-01 | 0.206 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.292341e-01 | 0.201 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.292341e-01 | 0.201 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.292341e-01 | 0.201 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 6.292341e-01 | 0.201 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 6.292341e-01 | 0.201 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 6.347080e-01 | 0.197 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 6.347080e-01 | 0.197 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 6.347080e-01 | 0.197 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 6.363996e-01 | 0.196 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.416369e-01 | 0.193 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 6.426785e-01 | 0.192 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 6.426785e-01 | 0.192 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 6.426785e-01 | 0.192 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 6.429612e-01 | 0.192 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 6.446892e-01 | 0.191 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.458649e-01 | 0.190 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.458649e-01 | 0.190 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 6.458649e-01 | 0.190 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.458649e-01 | 0.190 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.458649e-01 | 0.190 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.458649e-01 | 0.190 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 6.458649e-01 | 0.190 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.458649e-01 | 0.190 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.458649e-01 | 0.190 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.458649e-01 | 0.190 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 6.458649e-01 | 0.190 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.458649e-01 | 0.190 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 6.458649e-01 | 0.190 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.458649e-01 | 0.190 | 0 | 0 |
| NGF-independant TRKA activation | R-HSA-187024 | 6.458649e-01 | 0.190 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 6.458649e-01 | 0.190 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.458649e-01 | 0.190 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.458649e-01 | 0.190 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 6.458649e-01 | 0.190 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 6.458649e-01 | 0.190 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.458649e-01 | 0.190 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.458649e-01 | 0.190 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 6.458649e-01 | 0.190 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.458649e-01 | 0.190 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.458649e-01 | 0.190 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 6.458649e-01 | 0.190 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.464985e-01 | 0.189 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 6.468906e-01 | 0.189 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 6.468906e-01 | 0.189 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 6.468906e-01 | 0.189 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 6.468906e-01 | 0.189 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.468906e-01 | 0.189 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.468906e-01 | 0.189 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 6.468906e-01 | 0.189 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 6.479702e-01 | 0.188 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.511470e-01 | 0.186 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 6.516238e-01 | 0.186 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.552221e-01 | 0.184 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.552221e-01 | 0.184 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 6.552221e-01 | 0.184 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 6.552221e-01 | 0.184 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.552221e-01 | 0.184 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.559092e-01 | 0.183 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.559092e-01 | 0.183 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.559092e-01 | 0.183 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 6.599213e-01 | 0.181 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 6.599213e-01 | 0.181 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.647629e-01 | 0.177 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 6.647629e-01 | 0.177 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.647629e-01 | 0.177 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 6.647629e-01 | 0.177 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 6.660462e-01 | 0.176 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.660462e-01 | 0.176 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.660462e-01 | 0.176 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 6.690484e-01 | 0.175 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 6.708517e-01 | 0.173 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 6.708517e-01 | 0.173 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 6.708517e-01 | 0.173 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 6.708517e-01 | 0.173 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 6.743049e-01 | 0.171 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 6.743049e-01 | 0.171 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 6.743049e-01 | 0.171 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 6.743049e-01 | 0.171 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 6.760287e-01 | 0.170 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 6.773268e-01 | 0.169 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.773268e-01 | 0.169 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.773268e-01 | 0.169 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 6.773268e-01 | 0.169 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 6.773268e-01 | 0.169 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.773268e-01 | 0.169 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.781575e-01 | 0.169 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 6.781575e-01 | 0.169 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 6.798736e-01 | 0.168 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 6.798736e-01 | 0.168 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 6.798736e-01 | 0.168 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 6.798736e-01 | 0.168 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 6.798736e-01 | 0.168 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 6.835248e-01 | 0.165 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.835248e-01 | 0.165 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.835248e-01 | 0.165 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.835248e-01 | 0.165 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 6.858962e-01 | 0.164 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 6.858962e-01 | 0.164 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.858962e-01 | 0.164 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 6.864887e-01 | 0.163 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.889721e-01 | 0.162 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.889721e-01 | 0.162 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.889721e-01 | 0.162 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 6.889721e-01 | 0.162 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.889721e-01 | 0.162 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.889721e-01 | 0.162 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.889721e-01 | 0.162 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.889721e-01 | 0.162 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 6.923902e-01 | 0.160 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 6.929993e-01 | 0.159 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 6.929993e-01 | 0.159 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.003949e-01 | 0.155 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 7.003949e-01 | 0.155 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.003949e-01 | 0.155 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 7.003949e-01 | 0.155 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 7.003949e-01 | 0.155 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 7.031906e-01 | 0.153 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 7.031906e-01 | 0.153 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.031906e-01 | 0.153 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.031906e-01 | 0.153 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 7.031906e-01 | 0.153 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 7.031906e-01 | 0.153 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.031906e-01 | 0.153 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.031906e-01 | 0.153 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.055879e-01 | 0.151 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 7.055879e-01 | 0.151 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 7.055879e-01 | 0.151 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 7.055879e-01 | 0.151 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 7.055879e-01 | 0.151 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 7.055879e-01 | 0.151 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 7.055879e-01 | 0.151 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 7.055879e-01 | 0.151 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.055879e-01 | 0.151 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 7.060709e-01 | 0.151 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.060709e-01 | 0.151 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 7.075159e-01 | 0.150 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.077728e-01 | 0.150 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.109450e-01 | 0.148 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.150008e-01 | 0.146 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.150008e-01 | 0.146 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.166492e-01 | 0.145 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 7.166492e-01 | 0.145 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 7.166492e-01 | 0.145 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.226840e-01 | 0.141 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 7.226840e-01 | 0.141 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 7.242475e-01 | 0.140 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.252871e-01 | 0.139 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 7.252871e-01 | 0.139 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 7.268142e-01 | 0.139 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 7.268343e-01 | 0.139 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.268343e-01 | 0.139 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.268343e-01 | 0.139 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 7.268343e-01 | 0.139 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 7.268343e-01 | 0.139 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.268343e-01 | 0.139 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 7.268343e-01 | 0.139 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 7.268343e-01 | 0.139 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.268343e-01 | 0.139 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 7.268343e-01 | 0.139 | 0 | 0 |
| Activation of TRKA receptors | R-HSA-187015 | 7.268343e-01 | 0.139 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 7.268343e-01 | 0.139 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 7.268343e-01 | 0.139 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.268343e-01 | 0.139 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.281385e-01 | 0.138 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.281385e-01 | 0.138 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.281385e-01 | 0.138 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 7.281385e-01 | 0.138 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.288101e-01 | 0.137 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 7.306099e-01 | 0.136 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 7.317524e-01 | 0.136 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 7.317524e-01 | 0.136 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 7.317524e-01 | 0.136 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 7.317524e-01 | 0.136 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 7.317524e-01 | 0.136 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 7.317524e-01 | 0.136 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 7.317524e-01 | 0.136 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 7.317524e-01 | 0.136 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 7.317524e-01 | 0.136 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.317524e-01 | 0.136 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.322837e-01 | 0.135 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.322837e-01 | 0.135 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 7.370673e-01 | 0.132 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 7.400289e-01 | 0.131 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 7.445808e-01 | 0.128 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 7.445808e-01 | 0.128 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.445808e-01 | 0.128 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.445808e-01 | 0.128 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.458860e-01 | 0.127 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.458860e-01 | 0.127 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.458860e-01 | 0.127 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 7.458860e-01 | 0.127 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.467698e-01 | 0.127 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.468345e-01 | 0.127 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.473781e-01 | 0.126 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.478087e-01 | 0.126 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.550454e-01 | 0.122 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 7.555001e-01 | 0.122 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 7.559119e-01 | 0.122 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 7.559119e-01 | 0.122 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.559119e-01 | 0.122 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 7.559119e-01 | 0.122 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 7.583306e-01 | 0.120 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.600894e-01 | 0.119 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.600894e-01 | 0.119 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.600894e-01 | 0.119 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.600894e-01 | 0.119 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.600894e-01 | 0.119 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.600894e-01 | 0.119 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 7.600894e-01 | 0.119 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.600894e-01 | 0.119 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 7.600894e-01 | 0.119 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 7.600894e-01 | 0.119 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.600894e-01 | 0.119 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 7.600894e-01 | 0.119 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.600894e-01 | 0.119 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.600894e-01 | 0.119 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.600894e-01 | 0.119 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.600894e-01 | 0.119 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.600894e-01 | 0.119 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 7.600894e-01 | 0.119 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.602767e-01 | 0.119 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 7.608750e-01 | 0.119 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 7.616925e-01 | 0.118 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 7.642463e-01 | 0.117 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 7.653194e-01 | 0.116 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.653194e-01 | 0.116 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 7.657317e-01 | 0.116 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.674702e-01 | 0.115 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 7.694071e-01 | 0.114 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 7.752344e-01 | 0.111 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.764854e-01 | 0.110 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 7.772752e-01 | 0.109 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 7.772752e-01 | 0.109 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.776830e-01 | 0.109 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 7.781667e-01 | 0.109 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 7.781667e-01 | 0.109 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 7.781667e-01 | 0.109 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 7.781667e-01 | 0.109 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 7.781667e-01 | 0.109 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 7.781667e-01 | 0.109 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 7.829996e-01 | 0.106 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 7.829996e-01 | 0.106 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.835253e-01 | 0.106 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.870715e-01 | 0.104 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.878870e-01 | 0.104 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.886467e-01 | 0.103 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 7.886467e-01 | 0.103 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 7.892977e-01 | 0.103 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.892977e-01 | 0.103 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.892977e-01 | 0.103 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 7.892977e-01 | 0.103 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.892977e-01 | 0.103 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.892977e-01 | 0.103 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.892977e-01 | 0.103 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.892977e-01 | 0.103 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.892977e-01 | 0.103 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.892977e-01 | 0.103 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 7.892977e-01 | 0.103 | 0 | 0 |
| Lysosomal oligosaccharide catabolism | R-HSA-8853383 | 7.892977e-01 | 0.103 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.892977e-01 | 0.103 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.892977e-01 | 0.103 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.892977e-01 | 0.103 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 7.909427e-01 | 0.102 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 7.927726e-01 | 0.101 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 7.958133e-01 | 0.099 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.961759e-01 | 0.099 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.961759e-01 | 0.099 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 7.971314e-01 | 0.098 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 7.986224e-01 | 0.098 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 7.986224e-01 | 0.098 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.986224e-01 | 0.098 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 7.986224e-01 | 0.098 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.986224e-01 | 0.098 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.986224e-01 | 0.098 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 7.986224e-01 | 0.098 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 7.986224e-01 | 0.098 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 7.998256e-01 | 0.097 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 8.005466e-01 | 0.097 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.005466e-01 | 0.097 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.005466e-01 | 0.097 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 8.005466e-01 | 0.097 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.010855e-01 | 0.096 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.010855e-01 | 0.096 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.012217e-01 | 0.096 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.012217e-01 | 0.096 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 8.018029e-01 | 0.096 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.029837e-01 | 0.095 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.036095e-01 | 0.095 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.068914e-01 | 0.093 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.073913e-01 | 0.093 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.073913e-01 | 0.093 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 8.081097e-01 | 0.093 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.107477e-01 | 0.091 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.132088e-01 | 0.090 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.135386e-01 | 0.090 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.149514e-01 | 0.089 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.149514e-01 | 0.089 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.149514e-01 | 0.089 | 0 | 0 |
| Metabolism of serotonin | R-HSA-380612 | 8.149514e-01 | 0.089 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 8.149514e-01 | 0.089 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 8.149514e-01 | 0.089 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 8.149514e-01 | 0.089 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.149514e-01 | 0.089 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 8.149514e-01 | 0.089 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 8.149514e-01 | 0.089 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.149514e-01 | 0.089 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 8.149514e-01 | 0.089 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.149514e-01 | 0.089 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 8.158053e-01 | 0.088 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 8.158053e-01 | 0.088 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.164302e-01 | 0.088 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.164302e-01 | 0.088 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.164302e-01 | 0.088 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.164308e-01 | 0.088 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.164308e-01 | 0.088 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.173871e-01 | 0.088 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 8.173871e-01 | 0.088 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.173871e-01 | 0.088 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 8.173871e-01 | 0.088 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.173871e-01 | 0.088 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 8.177671e-01 | 0.087 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.218012e-01 | 0.085 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.230954e-01 | 0.085 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.279486e-01 | 0.082 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.279486e-01 | 0.082 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 8.312256e-01 | 0.080 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.312256e-01 | 0.080 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.312256e-01 | 0.080 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 8.312256e-01 | 0.080 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.312256e-01 | 0.080 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 8.324020e-01 | 0.080 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.345693e-01 | 0.079 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 8.345693e-01 | 0.079 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.345693e-01 | 0.079 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.354703e-01 | 0.078 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 8.374831e-01 | 0.077 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.374831e-01 | 0.077 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 8.374831e-01 | 0.077 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 8.374831e-01 | 0.077 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 8.374831e-01 | 0.077 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.374831e-01 | 0.077 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 8.374831e-01 | 0.077 | 0 | 0 |
| Cholesterol biosynthesis via desmosterol | R-HSA-6807047 | 8.374831e-01 | 0.077 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 8.374831e-01 | 0.077 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.374831e-01 | 0.077 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 8.374831e-01 | 0.077 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 8.374831e-01 | 0.077 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 8.374831e-01 | 0.077 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.394047e-01 | 0.076 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.394047e-01 | 0.076 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.402335e-01 | 0.076 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.418233e-01 | 0.075 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 8.418233e-01 | 0.075 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 8.449485e-01 | 0.073 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.449840e-01 | 0.073 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.449840e-01 | 0.073 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.462534e-01 | 0.072 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.462534e-01 | 0.072 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.498085e-01 | 0.071 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 8.502761e-01 | 0.070 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.502761e-01 | 0.070 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.502761e-01 | 0.070 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.502761e-01 | 0.070 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 8.502761e-01 | 0.070 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 8.502761e-01 | 0.070 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.502761e-01 | 0.070 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.542425e-01 | 0.068 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 8.555444e-01 | 0.068 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 8.572724e-01 | 0.067 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 8.572724e-01 | 0.067 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 8.572724e-01 | 0.067 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.572724e-01 | 0.067 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 8.572724e-01 | 0.067 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.572724e-01 | 0.067 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.572724e-01 | 0.067 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.572724e-01 | 0.067 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.572724e-01 | 0.067 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 8.572724e-01 | 0.067 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 8.572724e-01 | 0.067 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.576095e-01 | 0.067 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.576445e-01 | 0.067 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.577577e-01 | 0.067 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.577577e-01 | 0.067 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 8.577577e-01 | 0.067 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.577577e-01 | 0.067 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.577577e-01 | 0.067 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 8.580527e-01 | 0.066 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.624273e-01 | 0.064 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.636519e-01 | 0.064 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.646119e-01 | 0.063 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 8.646119e-01 | 0.063 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 8.646119e-01 | 0.063 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.660036e-01 | 0.062 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.660036e-01 | 0.062 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 8.673114e-01 | 0.062 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.683080e-01 | 0.061 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.683080e-01 | 0.061 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 8.683080e-01 | 0.061 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.694664e-01 | 0.061 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 8.695993e-01 | 0.061 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.701499e-01 | 0.060 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 8.708683e-01 | 0.060 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.722440e-01 | 0.059 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.746531e-01 | 0.058 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.746531e-01 | 0.058 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.746531e-01 | 0.058 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.746531e-01 | 0.058 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.746531e-01 | 0.058 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.746531e-01 | 0.058 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 8.746531e-01 | 0.058 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.746531e-01 | 0.058 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.746531e-01 | 0.058 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.746531e-01 | 0.058 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.746531e-01 | 0.058 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.746531e-01 | 0.058 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.776777e-01 | 0.057 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 8.776777e-01 | 0.057 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 8.776777e-01 | 0.057 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 8.776777e-01 | 0.057 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.776777e-01 | 0.057 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.782768e-01 | 0.056 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.782768e-01 | 0.056 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.782768e-01 | 0.056 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.782768e-01 | 0.056 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.782768e-01 | 0.056 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 8.805612e-01 | 0.055 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 8.818389e-01 | 0.055 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.859174e-01 | 0.053 | 1 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.877419e-01 | 0.052 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.895701e-01 | 0.051 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.895701e-01 | 0.051 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.895701e-01 | 0.051 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 8.895701e-01 | 0.051 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.895701e-01 | 0.051 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.895701e-01 | 0.051 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.895701e-01 | 0.051 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.895701e-01 | 0.051 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.896557e-01 | 0.051 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 8.899181e-01 | 0.051 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.899181e-01 | 0.051 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 8.899181e-01 | 0.051 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 8.899181e-01 | 0.051 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.899181e-01 | 0.051 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.899181e-01 | 0.051 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.899181e-01 | 0.051 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.899181e-01 | 0.051 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 8.899181e-01 | 0.051 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.899181e-01 | 0.051 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.899181e-01 | 0.051 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 8.906948e-01 | 0.050 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.906948e-01 | 0.050 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 8.930876e-01 | 0.049 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.935671e-01 | 0.049 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 8.940800e-01 | 0.049 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 8.957426e-01 | 0.048 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.962638e-01 | 0.048 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 8.962638e-01 | 0.048 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.978620e-01 | 0.047 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 9.000508e-01 | 0.046 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.000508e-01 | 0.046 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.000508e-01 | 0.046 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.000508e-01 | 0.046 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.000508e-01 | 0.046 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.000508e-01 | 0.046 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.003471e-01 | 0.046 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.003810e-01 | 0.046 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.003810e-01 | 0.046 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.011940e-01 | 0.045 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.022771e-01 | 0.045 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.032450e-01 | 0.044 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 9.033249e-01 | 0.044 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 9.033249e-01 | 0.044 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 9.033249e-01 | 0.044 | 0 | 0 |
| The activation of arylsulfatases | R-HSA-1663150 | 9.033249e-01 | 0.044 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 9.033249e-01 | 0.044 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 9.033249e-01 | 0.044 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.033249e-01 | 0.044 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.033249e-01 | 0.044 | 0 | 0 |
| Glycerophospholipid catabolism | R-HSA-6814848 | 9.033249e-01 | 0.044 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 9.033249e-01 | 0.044 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 9.033249e-01 | 0.044 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 9.033249e-01 | 0.044 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.033249e-01 | 0.044 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.033249e-01 | 0.044 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.043479e-01 | 0.044 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 9.055405e-01 | 0.043 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.086781e-01 | 0.042 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.086781e-01 | 0.042 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.086781e-01 | 0.042 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.101975e-01 | 0.041 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.101975e-01 | 0.041 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.101975e-01 | 0.041 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.101975e-01 | 0.041 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.101975e-01 | 0.041 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.105145e-01 | 0.041 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.118678e-01 | 0.040 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.118690e-01 | 0.040 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.118690e-01 | 0.040 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.118690e-01 | 0.040 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.150995e-01 | 0.039 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 9.150995e-01 | 0.039 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.150995e-01 | 0.039 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 9.150995e-01 | 0.039 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 9.150995e-01 | 0.039 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 9.150995e-01 | 0.039 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 9.150995e-01 | 0.039 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 9.150995e-01 | 0.039 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.150995e-01 | 0.039 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.166242e-01 | 0.038 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.166242e-01 | 0.038 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.166242e-01 | 0.038 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.188585e-01 | 0.037 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 9.191014e-01 | 0.037 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 9.191014e-01 | 0.037 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 9.191014e-01 | 0.037 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.191014e-01 | 0.037 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.191014e-01 | 0.037 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.191014e-01 | 0.037 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.204884e-01 | 0.036 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.204884e-01 | 0.036 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.230203e-01 | 0.035 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.239348e-01 | 0.034 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.243262e-01 | 0.034 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.253472e-01 | 0.034 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 9.253472e-01 | 0.034 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.254407e-01 | 0.034 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 9.254407e-01 | 0.034 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 9.254407e-01 | 0.034 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 9.254407e-01 | 0.034 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 9.254407e-01 | 0.034 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 9.254407e-01 | 0.034 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 9.254407e-01 | 0.034 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.271692e-01 | 0.033 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.271692e-01 | 0.033 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.271692e-01 | 0.033 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.271692e-01 | 0.033 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.289313e-01 | 0.032 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.304327e-01 | 0.031 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.306534e-01 | 0.031 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.306534e-01 | 0.031 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.313648e-01 | 0.031 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.340921e-01 | 0.030 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.340921e-01 | 0.030 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.345228e-01 | 0.029 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 9.345228e-01 | 0.029 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 9.345228e-01 | 0.029 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 9.345228e-01 | 0.029 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 9.345228e-01 | 0.029 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 9.345228e-01 | 0.029 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 9.345228e-01 | 0.029 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 9.345228e-01 | 0.029 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 9.345228e-01 | 0.029 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 9.345228e-01 | 0.029 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 9.345228e-01 | 0.029 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 9.345228e-01 | 0.029 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.345228e-01 | 0.029 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 9.345228e-01 | 0.029 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.369401e-01 | 0.028 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.374428e-01 | 0.028 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.390849e-01 | 0.027 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.390849e-01 | 0.027 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.410779e-01 | 0.026 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.410779e-01 | 0.026 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.424796e-01 | 0.026 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.424796e-01 | 0.026 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.424990e-01 | 0.026 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.424990e-01 | 0.026 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.424990e-01 | 0.026 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.424990e-01 | 0.026 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.424990e-01 | 0.026 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 9.424990e-01 | 0.026 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.424990e-01 | 0.026 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 9.424990e-01 | 0.026 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 9.424990e-01 | 0.026 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 9.424990e-01 | 0.026 | 0 | 0 |
| GDP-fucose biosynthesis | R-HSA-6787639 | 9.424990e-01 | 0.026 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 9.424990e-01 | 0.026 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 9.424990e-01 | 0.026 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.437348e-01 | 0.025 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 9.438244e-01 | 0.025 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.463532e-01 | 0.024 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.468730e-01 | 0.024 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.468730e-01 | 0.024 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.470469e-01 | 0.024 | 1 | 1 |
| Neurotransmitter clearance | R-HSA-112311 | 9.470469e-01 | 0.024 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.470595e-01 | 0.024 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.476640e-01 | 0.023 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.480618e-01 | 0.023 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.480618e-01 | 0.023 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.494257e-01 | 0.023 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 9.495041e-01 | 0.023 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.495041e-01 | 0.023 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 9.495041e-01 | 0.023 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.495041e-01 | 0.023 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.495041e-01 | 0.023 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.495041e-01 | 0.023 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.496783e-01 | 0.022 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.512823e-01 | 0.022 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 9.520848e-01 | 0.021 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.524105e-01 | 0.021 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.524365e-01 | 0.021 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.553529e-01 | 0.020 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.556561e-01 | 0.020 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.556561e-01 | 0.020 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.556561e-01 | 0.020 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 9.556561e-01 | 0.020 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.556561e-01 | 0.020 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.563849e-01 | 0.019 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.565915e-01 | 0.019 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.587984e-01 | 0.018 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.608217e-01 | 0.017 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 9.610589e-01 | 0.017 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.610589e-01 | 0.017 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.610589e-01 | 0.017 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.610589e-01 | 0.017 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.610589e-01 | 0.017 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.625317e-01 | 0.017 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.625680e-01 | 0.017 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.643449e-01 | 0.016 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.643871e-01 | 0.016 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.656336e-01 | 0.015 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.656336e-01 | 0.015 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.657549e-01 | 0.015 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 9.658037e-01 | 0.015 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.658037e-01 | 0.015 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.658037e-01 | 0.015 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.658037e-01 | 0.015 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.658037e-01 | 0.015 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.658037e-01 | 0.015 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.658037e-01 | 0.015 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.658037e-01 | 0.015 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.661811e-01 | 0.015 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.665912e-01 | 0.015 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.687429e-01 | 0.014 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.688161e-01 | 0.014 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.691903e-01 | 0.014 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.697778e-01 | 0.013 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.699706e-01 | 0.013 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.699706e-01 | 0.013 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 9.699706e-01 | 0.013 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.699706e-01 | 0.013 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.713845e-01 | 0.013 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.719774e-01 | 0.012 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.722010e-01 | 0.012 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.723908e-01 | 0.012 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.723908e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.723908e-01 | 0.012 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.723908e-01 | 0.012 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.726454e-01 | 0.012 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.730223e-01 | 0.012 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.733396e-01 | 0.012 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.736300e-01 | 0.012 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.736300e-01 | 0.012 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.736300e-01 | 0.012 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.759436e-01 | 0.011 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.761384e-01 | 0.010 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.768436e-01 | 0.010 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.768436e-01 | 0.010 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 9.768436e-01 | 0.010 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.768436e-01 | 0.010 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.768436e-01 | 0.010 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.777249e-01 | 0.010 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.777249e-01 | 0.010 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.778560e-01 | 0.010 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.778560e-01 | 0.010 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.778560e-01 | 0.010 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.796658e-01 | 0.009 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.796658e-01 | 0.009 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.796658e-01 | 0.009 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 9.796658e-01 | 0.009 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.796658e-01 | 0.009 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.796658e-01 | 0.009 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.796658e-01 | 0.009 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.808999e-01 | 0.008 | 0 | 0 |
| Alpha-oxidation of phytanate | R-HSA-389599 | 9.821442e-01 | 0.008 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.821442e-01 | 0.008 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.821442e-01 | 0.008 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.821507e-01 | 0.008 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.822665e-01 | 0.008 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.822665e-01 | 0.008 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.822665e-01 | 0.008 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.836461e-01 | 0.007 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.841390e-01 | 0.007 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.841390e-01 | 0.007 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.843206e-01 | 0.007 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.843206e-01 | 0.007 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.843206e-01 | 0.007 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.843206e-01 | 0.007 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.843206e-01 | 0.007 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.849114e-01 | 0.007 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.856532e-01 | 0.006 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.859022e-01 | 0.006 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.862318e-01 | 0.006 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.862318e-01 | 0.006 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.862318e-01 | 0.006 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.862318e-01 | 0.006 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.865892e-01 | 0.006 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.871678e-01 | 0.006 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.875547e-01 | 0.005 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.879102e-01 | 0.005 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.879102e-01 | 0.005 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.880572e-01 | 0.005 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.886743e-01 | 0.005 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.886743e-01 | 0.005 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.886743e-01 | 0.005 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.886743e-01 | 0.005 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.886799e-01 | 0.005 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.893841e-01 | 0.005 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.893841e-01 | 0.005 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.898834e-01 | 0.004 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.906457e-01 | 0.004 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 9.906783e-01 | 0.004 | 0 | 0 |
| Mucopolysaccharidoses | R-HSA-2206281 | 9.906783e-01 | 0.004 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.907448e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.909363e-01 | 0.004 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.913811e-01 | 0.004 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.913811e-01 | 0.004 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.913811e-01 | 0.004 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.918149e-01 | 0.004 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.918149e-01 | 0.004 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.921155e-01 | 0.003 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.921155e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.923705e-01 | 0.003 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.928129e-01 | 0.003 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.928129e-01 | 0.003 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.928165e-01 | 0.003 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.928931e-01 | 0.003 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.935874e-01 | 0.003 | 0 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.936893e-01 | 0.003 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.942591e-01 | 0.003 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.944588e-01 | 0.002 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.944588e-01 | 0.002 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.944588e-01 | 0.002 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.950441e-01 | 0.002 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.950936e-01 | 0.002 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.951346e-01 | 0.002 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.951346e-01 | 0.002 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.951346e-01 | 0.002 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.951346e-01 | 0.002 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.951346e-01 | 0.002 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.957040e-01 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | R-HSA-193775 | 9.957280e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.959406e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.962149e-01 | 0.002 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.962490e-01 | 0.002 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.962490e-01 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.963098e-01 | 0.002 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.965959e-01 | 0.001 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.967065e-01 | 0.001 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.967065e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.967065e-01 | 0.001 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.967065e-01 | 0.001 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.967065e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.967771e-01 | 0.001 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.968303e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.968303e-01 | 0.001 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.970669e-01 | 0.001 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.971083e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.971083e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.973590e-01 | 0.001 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.973671e-01 | 0.001 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.974435e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.974610e-01 | 0.001 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.974610e-01 | 0.001 | 1 | 1 |
| SLC transporter disorders | R-HSA-5619102 | 9.975814e-01 | 0.001 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.977708e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.977794e-01 | 0.001 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.977794e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.977794e-01 | 0.001 | 1 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.977794e-01 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.979738e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.979738e-01 | 0.001 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.980058e-01 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.980427e-01 | 0.001 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.982095e-01 | 0.001 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.982816e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.983928e-01 | 0.001 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.984134e-01 | 0.001 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.984236e-01 | 0.001 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.985577e-01 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.985724e-01 | 0.001 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.985724e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.986753e-01 | 0.001 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.987138e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.987302e-01 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.988370e-01 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.988370e-01 | 0.001 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.989592e-01 | 0.000 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.989789e-01 | 0.000 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.989789e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.991035e-01 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.991725e-01 | 0.000 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.992129e-01 | 0.000 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.992136e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.992505e-01 | 0.000 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.993090e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.993281e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.993427e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.993464e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.993733e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.993934e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.994432e-01 | 0.000 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.995607e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.996658e-01 | 0.000 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.997223e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.997223e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.997328e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.997562e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.997613e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.997818e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.998039e-01 | 0.000 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.998350e-01 | 0.000 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.998350e-01 | 0.000 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.998552e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.998729e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.998743e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.998818e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.998993e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.999020e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999020e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999133e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999140e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999140e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999197e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999245e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999261e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999309e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.999418e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999433e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999516e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999539e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999546e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999549e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999607e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999646e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.999655e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999661e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.999698e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999734e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.999795e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999796e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999838e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999861e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999866e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999870e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999878e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999907e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999937e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999957e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999968e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999970e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999979e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999979e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.999985e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999997e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999999e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 1 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 7.881584e-12 | 11.103 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.588940e-11 | 10.445 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 4.967893e-11 | 10.304 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.215939e-11 | 10.283 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 6.376529e-10 | 9.195 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 8.132044e-10 | 9.090 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.467161e-09 | 8.834 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.646277e-09 | 8.783 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.278927e-09 | 8.642 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.283059e-09 | 8.641 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.922001e-09 | 8.308 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.398396e-08 | 7.854 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 1.438414e-08 | 7.842 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.443782e-08 | 7.463 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 3.282195e-08 | 7.484 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.270915e-07 | 6.896 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.526788e-07 | 6.816 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 1.748367e-07 | 6.757 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.921749e-07 | 6.716 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.687763e-07 | 6.571 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 5.841248e-07 | 6.233 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.635393e-07 | 6.249 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.685176e-07 | 6.175 | 1 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.489185e-07 | 6.071 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 8.628818e-07 | 6.064 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 9.014424e-07 | 6.045 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.030362e-06 | 5.987 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.175100e-06 | 5.930 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.256471e-06 | 5.901 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.605139e-06 | 5.794 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.802528e-06 | 5.744 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.329866e-06 | 5.633 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.329866e-06 | 5.633 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.584876e-06 | 5.588 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.658421e-06 | 5.575 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.140065e-06 | 5.212 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 6.979118e-06 | 5.156 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.952326e-06 | 5.100 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.957631e-06 | 5.048 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.068041e-05 | 4.971 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.080420e-05 | 4.966 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.176323e-05 | 4.929 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.309022e-05 | 4.883 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 1.318170e-05 | 4.880 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 1.318170e-05 | 4.880 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.343244e-05 | 4.872 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.680754e-05 | 4.774 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 1.789476e-05 | 4.747 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.209787e-05 | 4.656 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 2.240662e-05 | 4.650 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 2.240662e-05 | 4.650 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 2.477706e-05 | 4.606 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.936732e-05 | 4.532 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 3.331558e-05 | 4.477 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.629218e-05 | 4.440 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 3.895977e-05 | 4.409 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.625986e-05 | 4.335 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 4.962282e-05 | 4.304 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.689996e-05 | 4.245 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.689996e-05 | 4.245 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.689996e-05 | 4.245 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.689996e-05 | 4.245 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 6.396462e-05 | 4.194 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 6.396566e-05 | 4.194 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.932185e-05 | 4.159 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 7.129699e-05 | 4.147 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 7.846557e-05 | 4.105 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.392052e-05 | 4.076 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 8.770727e-05 | 4.057 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.114862e-04 | 3.953 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.217327e-04 | 3.915 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.320118e-04 | 3.879 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.420301e-04 | 3.848 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.543110e-04 | 3.812 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.737984e-04 | 3.760 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.819602e-04 | 3.740 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.768556e-04 | 3.752 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.770187e-04 | 3.752 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.876389e-04 | 3.727 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.876389e-04 | 3.727 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 2.033574e-04 | 3.692 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.201945e-04 | 3.657 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.376677e-04 | 3.624 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.260205e-04 | 3.646 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.334937e-04 | 3.632 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.334937e-04 | 3.632 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.376677e-04 | 3.624 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.332001e-04 | 3.632 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 2.661361e-04 | 3.575 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.891121e-04 | 3.539 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.226643e-04 | 3.491 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.452861e-04 | 3.462 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.452861e-04 | 3.462 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 3.502216e-04 | 3.456 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.738202e-04 | 3.427 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 3.762250e-04 | 3.425 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.793687e-04 | 3.421 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 3.797984e-04 | 3.420 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 4.257562e-04 | 3.371 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.045985e-04 | 3.393 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 4.589677e-04 | 3.338 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 4.761763e-04 | 3.322 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.945602e-04 | 3.306 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.996983e-04 | 3.301 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 5.417788e-04 | 3.266 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.820107e-04 | 3.235 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 6.306309e-04 | 3.200 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.479657e-04 | 3.188 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.510092e-04 | 3.186 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.287382e-04 | 3.137 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 7.315289e-04 | 3.136 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.229125e-04 | 3.141 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 7.229125e-04 | 3.141 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 6.910647e-04 | 3.160 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 7.229125e-04 | 3.141 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.374311e-04 | 3.132 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 7.441609e-04 | 3.128 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 7.994875e-04 | 3.097 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 8.274926e-04 | 3.082 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 8.274926e-04 | 3.082 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 8.486103e-04 | 3.071 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 8.486103e-04 | 3.071 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.936052e-04 | 3.049 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.519509e-04 | 3.070 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 8.551481e-04 | 3.068 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 9.304753e-04 | 3.031 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 9.890319e-04 | 3.005 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.026408e-03 | 2.989 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 1.096768e-03 | 2.960 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.099063e-03 | 2.959 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.141288e-03 | 2.943 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.152392e-03 | 2.938 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.176092e-03 | 2.930 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.176681e-03 | 2.929 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.241151e-03 | 2.906 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 1.268932e-03 | 2.897 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.315884e-03 | 2.881 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.317771e-03 | 2.880 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 1.424488e-03 | 2.846 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.485484e-03 | 2.828 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.445791e-03 | 2.840 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.456017e-03 | 2.837 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.550982e-03 | 2.809 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.484609e-03 | 2.828 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.589713e-03 | 2.799 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 1.557878e-03 | 2.807 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.490684e-03 | 2.827 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.557878e-03 | 2.807 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 1.605279e-03 | 2.794 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.640500e-03 | 2.785 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.648635e-03 | 2.783 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.709041e-03 | 2.767 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.817988e-03 | 2.740 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.860261e-03 | 2.730 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.860261e-03 | 2.730 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.120442e-03 | 2.674 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 2.060500e-03 | 2.686 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 2.189123e-03 | 2.660 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 2.209503e-03 | 2.656 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 2.209503e-03 | 2.656 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.361778e-03 | 2.627 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 2.361778e-03 | 2.627 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.465321e-03 | 2.608 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.480681e-03 | 2.605 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.510962e-03 | 2.600 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.510962e-03 | 2.600 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.523015e-03 | 2.598 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.619947e-03 | 2.582 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.735862e-03 | 2.563 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 2.771288e-03 | 2.557 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.933181e-03 | 2.533 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.042823e-03 | 2.517 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.080519e-03 | 2.511 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.080519e-03 | 2.511 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.307196e-03 | 2.481 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 3.666472e-03 | 2.436 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.466234e-03 | 2.460 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.386698e-03 | 2.470 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 3.688375e-03 | 2.433 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.696671e-03 | 2.432 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 3.848227e-03 | 2.415 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.952247e-03 | 2.403 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.974931e-03 | 2.401 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 4.005213e-03 | 2.397 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.220145e-03 | 2.375 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 4.484287e-03 | 2.348 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 4.539059e-03 | 2.343 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 4.539059e-03 | 2.343 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 4.575676e-03 | 2.340 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 4.630712e-03 | 2.334 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.630712e-03 | 2.334 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.650789e-03 | 2.332 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.650789e-03 | 2.332 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.710508e-03 | 2.327 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.756244e-03 | 2.323 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.027735e-03 | 2.299 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.027735e-03 | 2.299 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 5.707060e-03 | 2.244 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 5.707060e-03 | 2.244 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 5.836728e-03 | 2.234 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 5.836728e-03 | 2.234 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.207373e-03 | 2.283 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 5.339361e-03 | 2.273 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 5.707060e-03 | 2.244 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 5.274787e-03 | 2.278 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 6.174974e-03 | 2.209 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 6.380231e-03 | 2.195 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.380231e-03 | 2.195 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.380231e-03 | 2.195 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.380231e-03 | 2.195 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.560854e-03 | 2.183 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 6.830081e-03 | 2.166 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 6.926219e-03 | 2.160 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 6.927661e-03 | 2.159 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 7.066200e-03 | 2.151 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.066200e-03 | 2.151 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 7.082007e-03 | 2.150 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 7.082007e-03 | 2.150 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.329237e-03 | 2.135 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 7.403025e-03 | 2.131 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 7.403025e-03 | 2.131 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 7.416898e-03 | 2.130 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 7.505135e-03 | 2.125 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 7.752614e-03 | 2.111 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 7.768825e-03 | 2.110 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.901388e-03 | 2.102 | 1 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 9.929420e-03 | 2.003 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 9.738728e-03 | 2.011 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.596526e-03 | 2.018 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.066417e-03 | 2.043 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.112555e-03 | 2.040 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 9.929420e-03 | 2.003 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 8.571010e-03 | 2.067 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.359301e-03 | 2.029 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.670588e-03 | 2.062 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 9.208744e-03 | 2.036 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 9.458316e-03 | 2.024 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 9.458316e-03 | 2.024 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 9.934689e-03 | 2.003 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.006177e-02 | 1.997 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 1.023330e-02 | 1.990 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.056828e-02 | 1.976 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.060198e-02 | 1.975 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.090938e-02 | 1.962 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.094466e-02 | 1.961 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 1.094466e-02 | 1.961 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 1.102059e-02 | 1.958 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.112380e-02 | 1.954 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.112380e-02 | 1.954 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.112380e-02 | 1.954 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.112380e-02 | 1.954 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.112380e-02 | 1.954 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.117812e-02 | 1.952 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.117812e-02 | 1.952 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.117812e-02 | 1.952 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.117812e-02 | 1.952 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.123586e-02 | 1.949 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 1.400835e-02 | 1.854 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.392984e-02 | 1.856 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.392984e-02 | 1.856 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.228725e-02 | 1.911 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.290275e-02 | 1.889 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.228468e-02 | 1.911 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.247117e-02 | 1.904 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 1.388000e-02 | 1.858 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 1.464476e-02 | 1.834 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.247117e-02 | 1.904 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.385269e-02 | 1.858 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.385269e-02 | 1.858 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.392984e-02 | 1.856 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.350395e-02 | 1.870 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.388000e-02 | 1.858 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.371112e-02 | 1.863 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.418086e-02 | 1.848 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 1.228468e-02 | 1.911 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 1.371112e-02 | 1.863 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.475076e-02 | 1.831 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.475076e-02 | 1.831 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.492979e-02 | 1.826 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.512130e-02 | 1.820 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.527841e-02 | 1.816 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.527841e-02 | 1.816 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.527841e-02 | 1.816 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.581477e-02 | 1.801 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.632066e-02 | 1.787 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.744020e-02 | 1.758 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.789222e-02 | 1.747 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.793805e-02 | 1.746 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.793805e-02 | 1.746 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.793805e-02 | 1.746 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.793805e-02 | 1.746 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.793805e-02 | 1.746 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 1.816819e-02 | 1.741 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 1.816819e-02 | 1.741 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.816819e-02 | 1.741 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 1.816819e-02 | 1.741 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.934089e-02 | 1.714 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 1.936662e-02 | 1.713 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.944198e-02 | 1.711 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.944198e-02 | 1.711 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 1.974767e-02 | 1.704 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 1.974767e-02 | 1.704 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 2.100934e-02 | 1.678 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.100934e-02 | 1.678 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 2.174813e-02 | 1.663 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.261850e-02 | 1.646 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.278030e-02 | 1.642 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.283282e-02 | 1.641 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.338737e-02 | 1.631 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.376460e-02 | 1.624 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.385798e-02 | 1.622 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.385798e-02 | 1.622 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.385798e-02 | 1.622 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 2.385798e-02 | 1.622 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 3.148713e-02 | 1.502 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 2.836123e-02 | 1.547 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 2.663392e-02 | 1.575 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 2.723320e-02 | 1.565 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.688593e-02 | 1.570 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 3.094595e-02 | 1.509 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 2.973961e-02 | 1.527 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 2.674999e-02 | 1.573 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 2.899578e-02 | 1.538 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 3.094595e-02 | 1.509 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.804442e-02 | 1.552 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.699178e-02 | 1.569 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 2.609632e-02 | 1.583 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 2.674999e-02 | 1.573 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 2.674999e-02 | 1.573 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 3.148713e-02 | 1.502 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.300641e-02 | 1.481 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.300641e-02 | 1.481 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.372390e-02 | 1.472 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.506351e-02 | 1.455 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 3.521077e-02 | 1.453 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 3.564406e-02 | 1.448 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.694128e-02 | 1.432 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 3.744160e-02 | 1.427 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.744160e-02 | 1.427 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.778269e-02 | 1.423 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 3.778269e-02 | 1.423 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 3.778269e-02 | 1.423 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.780461e-02 | 1.422 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.801281e-02 | 1.420 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.801281e-02 | 1.420 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 3.801281e-02 | 1.420 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 3.931567e-02 | 1.405 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.056388e-02 | 1.392 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.086985e-02 | 1.389 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 4.089974e-02 | 1.388 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 4.242249e-02 | 1.372 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 4.293444e-02 | 1.367 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 4.368957e-02 | 1.360 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.407021e-02 | 1.356 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.486316e-02 | 1.348 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.598964e-02 | 1.337 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.598964e-02 | 1.337 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 4.699202e-02 | 1.328 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.699202e-02 | 1.328 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.699202e-02 | 1.328 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 4.800804e-02 | 1.319 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.800804e-02 | 1.319 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.805871e-02 | 1.318 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 4.886947e-02 | 1.311 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 4.886947e-02 | 1.311 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.886947e-02 | 1.311 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 6.291595e-02 | 1.201 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 6.291595e-02 | 1.201 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 6.291595e-02 | 1.201 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 6.291595e-02 | 1.201 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 6.291595e-02 | 1.201 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 6.291595e-02 | 1.201 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 6.291595e-02 | 1.201 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 6.291595e-02 | 1.201 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 6.291595e-02 | 1.201 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 6.291595e-02 | 1.201 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 6.291595e-02 | 1.201 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 6.291595e-02 | 1.201 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 6.291595e-02 | 1.201 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.472455e-02 | 1.189 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.472455e-02 | 1.189 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 5.569651e-02 | 1.254 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 5.569651e-02 | 1.254 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 5.569651e-02 | 1.254 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 5.488890e-02 | 1.261 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 5.363431e-02 | 1.271 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.050923e-02 | 1.218 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.190521e-02 | 1.285 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.540906e-02 | 1.184 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.060542e-02 | 1.217 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.866163e-02 | 1.232 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.915858e-02 | 1.228 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 6.204459e-02 | 1.207 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 4.959944e-02 | 1.305 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.190521e-02 | 1.285 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.566621e-02 | 1.254 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 5.278775e-02 | 1.277 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 5.569651e-02 | 1.254 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.363431e-02 | 1.271 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 6.285632e-02 | 1.202 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 6.471330e-02 | 1.189 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.546781e-02 | 1.184 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 5.138803e-02 | 1.289 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 5.190521e-02 | 1.285 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 6.471330e-02 | 1.189 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 5.940480e-02 | 1.226 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 4.915465e-02 | 1.308 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.582781e-02 | 1.253 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.540906e-02 | 1.184 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.940480e-02 | 1.226 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.546781e-02 | 1.184 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.799757e-02 | 1.168 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 6.799757e-02 | 1.168 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 6.799757e-02 | 1.168 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.799757e-02 | 1.168 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 6.799757e-02 | 1.168 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 6.799757e-02 | 1.168 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.799757e-02 | 1.168 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 6.812491e-02 | 1.167 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.838329e-02 | 1.165 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 6.860009e-02 | 1.164 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.901646e-02 | 1.161 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.120176e-02 | 1.148 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 7.120176e-02 | 1.148 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 7.206085e-02 | 1.142 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.361827e-02 | 1.133 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.403722e-02 | 1.131 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 7.545617e-02 | 1.122 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.693090e-02 | 1.114 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 7.910603e-02 | 1.102 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 8.157749e-02 | 1.088 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 8.157749e-02 | 1.088 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 8.157749e-02 | 1.088 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 8.157749e-02 | 1.088 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 8.157749e-02 | 1.088 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 8.157749e-02 | 1.088 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 8.157749e-02 | 1.088 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.157749e-02 | 1.088 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.157749e-02 | 1.088 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.157749e-02 | 1.088 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.160094e-02 | 1.088 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.254354e-02 | 1.083 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.254354e-02 | 1.083 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 8.254354e-02 | 1.083 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 8.262390e-02 | 1.083 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 8.277221e-02 | 1.082 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 8.277221e-02 | 1.082 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.582641e-02 | 1.066 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.657728e-02 | 1.063 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 8.673192e-02 | 1.062 | 1 | 0 |
| PKA activation | R-HSA-163615 | 8.710207e-02 | 1.060 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.710207e-02 | 1.060 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 8.766667e-02 | 1.057 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.866407e-02 | 1.052 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 8.894573e-02 | 1.051 | 0 | 0 |
| Signaling by FGFR1 amplification mutants | R-HSA-1839120 | 9.213604e-02 | 1.036 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.444243e-02 | 1.025 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.444243e-02 | 1.025 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 9.482872e-02 | 1.023 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 9.528217e-02 | 1.021 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 9.528217e-02 | 1.021 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 9.528217e-02 | 1.021 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.591773e-02 | 1.018 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.608179e-02 | 1.017 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 9.632782e-02 | 1.016 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 9.635160e-02 | 1.016 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 9.638289e-02 | 1.016 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 9.638289e-02 | 1.016 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 9.638289e-02 | 1.016 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 9.638289e-02 | 1.016 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 9.703015e-02 | 1.013 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.244234e-01 | 0.905 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.023861e-01 | 0.990 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.023861e-01 | 0.990 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 1.238111e-01 | 0.907 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.238111e-01 | 0.907 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.238111e-01 | 0.907 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.466889e-01 | 0.834 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.466889e-01 | 0.834 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.466889e-01 | 0.834 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 1.293930e-01 | 0.888 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.421393e-01 | 0.847 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.421393e-01 | 0.847 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 1.220722e-01 | 0.913 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.269204e-01 | 0.896 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.292152e-01 | 0.889 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 1.292152e-01 | 0.889 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 1.398479e-01 | 0.854 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 1.206723e-01 | 0.918 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.397047e-01 | 0.855 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.189495e-01 | 0.925 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 1.271864e-01 | 0.896 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 1.038623e-01 | 0.984 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.266181e-01 | 0.898 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.266181e-01 | 0.898 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.962745e-02 | 1.002 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.155612e-01 | 0.937 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.036117e-01 | 0.985 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 1.017467e-01 | 0.992 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.130014e-01 | 0.947 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.271864e-01 | 0.896 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.266181e-01 | 0.898 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 1.293930e-01 | 0.888 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 1.238111e-01 | 0.907 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.189495e-01 | 0.925 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 1.043362e-01 | 0.982 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 9.847152e-02 | 1.007 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 9.969515e-02 | 1.001 | 1 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.996973e-02 | 1.000 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 1.247562e-01 | 0.904 | 1 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.115033e-01 | 0.953 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 1.023861e-01 | 0.990 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.130014e-01 | 0.947 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.052906e-01 | 0.978 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.309021e-01 | 0.883 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 1.092657e-01 | 0.962 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 1.238111e-01 | 0.907 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.123472e-01 | 0.949 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.293930e-01 | 0.888 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.269204e-01 | 0.896 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.269204e-01 | 0.896 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 1.398479e-01 | 0.854 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.429327e-01 | 0.845 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.184058e-01 | 0.927 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 1.341393e-01 | 0.872 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.052906e-01 | 0.978 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 1.052906e-01 | 0.978 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 1.052906e-01 | 0.978 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 1.271864e-01 | 0.896 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.408056e-01 | 0.851 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.189495e-01 | 0.925 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.121754e-01 | 0.950 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.043362e-01 | 0.982 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 1.238111e-01 | 0.907 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.385123e-01 | 0.859 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.962745e-02 | 1.002 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 1.466889e-01 | 0.834 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.293930e-01 | 0.888 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.271551e-01 | 0.896 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 1.271864e-01 | 0.896 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.052906e-01 | 0.978 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.271864e-01 | 0.896 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.421393e-01 | 0.847 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.122181e-01 | 0.950 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 1.238111e-01 | 0.907 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 1.123472e-01 | 0.949 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.134254e-01 | 0.945 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.089244e-01 | 0.963 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 1.474346e-01 | 0.831 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.474346e-01 | 0.831 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.474346e-01 | 0.831 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 1.474346e-01 | 0.831 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 1.474346e-01 | 0.831 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.474346e-01 | 0.831 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 1.479790e-01 | 0.830 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.481765e-01 | 0.829 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.521844e-01 | 0.818 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.559235e-01 | 0.807 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.562312e-01 | 0.806 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 1.578121e-01 | 0.802 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 1.578121e-01 | 0.802 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 1.578344e-01 | 0.802 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.584509e-01 | 0.800 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.586417e-01 | 0.800 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.589168e-01 | 0.799 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.589168e-01 | 0.799 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.589168e-01 | 0.799 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.589168e-01 | 0.799 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 1.602495e-01 | 0.795 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.604478e-01 | 0.795 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.604478e-01 | 0.795 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.604478e-01 | 0.795 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 1.620973e-01 | 0.790 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.620973e-01 | 0.790 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 1.647175e-01 | 0.783 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.661638e-01 | 0.779 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.662810e-01 | 0.779 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.663798e-01 | 0.779 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.663798e-01 | 0.779 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.663798e-01 | 0.779 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.663798e-01 | 0.779 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.663798e-01 | 0.779 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.708063e-01 | 0.767 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 1.708063e-01 | 0.767 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.738458e-01 | 0.760 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 1.741525e-01 | 0.759 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.742155e-01 | 0.759 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.758911e-01 | 0.755 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.761677e-01 | 0.754 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.765537e-01 | 0.753 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 1.783118e-01 | 0.749 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 1.823703e-01 | 0.739 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.833817e-01 | 0.737 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.833817e-01 | 0.737 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.833817e-01 | 0.737 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.833817e-01 | 0.737 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.858808e-01 | 0.731 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.861320e-01 | 0.730 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.861320e-01 | 0.730 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.861320e-01 | 0.730 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 1.861320e-01 | 0.730 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 1.864399e-01 | 0.729 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 1.881004e-01 | 0.726 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 1.889899e-01 | 0.724 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 1.889899e-01 | 0.724 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.896034e-01 | 0.722 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 1.911052e-01 | 0.719 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.911052e-01 | 0.719 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.911052e-01 | 0.719 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 1.941181e-01 | 0.712 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.948922e-01 | 0.710 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.948922e-01 | 0.710 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 1.948922e-01 | 0.710 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 1.948922e-01 | 0.710 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.948922e-01 | 0.710 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 1.948922e-01 | 0.710 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 1.948922e-01 | 0.710 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.948922e-01 | 0.710 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 1.948922e-01 | 0.710 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.948922e-01 | 0.710 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 1.959521e-01 | 0.708 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 1.959521e-01 | 0.708 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 2.620541e-01 | 0.582 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.620541e-01 | 0.582 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.620541e-01 | 0.582 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 2.620541e-01 | 0.582 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.620541e-01 | 0.582 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 2.620541e-01 | 0.582 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.620541e-01 | 0.582 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 3.331514e-01 | 0.477 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.331514e-01 | 0.477 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 3.331514e-01 | 0.477 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.331514e-01 | 0.477 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.331514e-01 | 0.477 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 3.331514e-01 | 0.477 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 3.331514e-01 | 0.477 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.331514e-01 | 0.477 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.317445e-01 | 0.635 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 2.317445e-01 | 0.635 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 2.317445e-01 | 0.635 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 2.689714e-01 | 0.570 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.689714e-01 | 0.570 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 2.689714e-01 | 0.570 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.689714e-01 | 0.570 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 2.689714e-01 | 0.570 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 2.689714e-01 | 0.570 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.689714e-01 | 0.570 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.974026e-01 | 0.401 | 0 | 0 |
| Signaling by plasma membrane FGFR1 fusions | R-HSA-8853336 | 3.974026e-01 | 0.401 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 3.974026e-01 | 0.401 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.974026e-01 | 0.401 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.974026e-01 | 0.401 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.974026e-01 | 0.401 | 0 | 0 |
| Classical Kir channels | R-HSA-1296053 | 3.974026e-01 | 0.401 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 3.061591e-01 | 0.514 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 3.061591e-01 | 0.514 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.061591e-01 | 0.514 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.061591e-01 | 0.514 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.485174e-01 | 0.605 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 2.065922e-01 | 0.685 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.276604e-01 | 0.643 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 3.429697e-01 | 0.465 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 3.429697e-01 | 0.465 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 3.429697e-01 | 0.465 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.429697e-01 | 0.465 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.492368e-01 | 0.603 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.492368e-01 | 0.603 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 3.028652e-01 | 0.519 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.791311e-01 | 0.421 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.791311e-01 | 0.421 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 2.935246e-01 | 0.532 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.935246e-01 | 0.532 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 3.160482e-01 | 0.500 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.895409e-01 | 0.538 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.849010e-01 | 0.415 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.849010e-01 | 0.415 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.849010e-01 | 0.415 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.219237e-01 | 0.492 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 3.614154e-01 | 0.442 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.932189e-01 | 0.533 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 2.462799e-01 | 0.609 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.807062e-01 | 0.552 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 2.807062e-01 | 0.552 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.090256e-01 | 0.510 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.840971e-01 | 0.416 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.614099e-01 | 0.442 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 3.249900e-01 | 0.488 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 3.249900e-01 | 0.488 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.812199e-01 | 0.419 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 3.023366e-01 | 0.520 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 2.524430e-01 | 0.598 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.219211e-01 | 0.654 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 2.776012e-01 | 0.557 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.832631e-01 | 0.548 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.832631e-01 | 0.548 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.776012e-01 | 0.557 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.086124e-01 | 0.681 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.028652e-01 | 0.519 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.791311e-01 | 0.421 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 3.597521e-01 | 0.444 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.791311e-01 | 0.421 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.791311e-01 | 0.421 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 2.555579e-01 | 0.593 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.251517e-01 | 0.648 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.245004e-01 | 0.489 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.492368e-01 | 0.603 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.216914e-01 | 0.493 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.429697e-01 | 0.465 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.895409e-01 | 0.538 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.664651e-01 | 0.574 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.776012e-01 | 0.557 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.776012e-01 | 0.557 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 2.251517e-01 | 0.648 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 3.693872e-01 | 0.433 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 3.061591e-01 | 0.514 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.061591e-01 | 0.514 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.829823e-01 | 0.548 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.470582e-01 | 0.607 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 3.023564e-01 | 0.519 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.834105e-01 | 0.548 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 3.597521e-01 | 0.444 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 3.597521e-01 | 0.444 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.824515e-01 | 0.549 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 3.614154e-01 | 0.442 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.609549e-01 | 0.583 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.511820e-01 | 0.454 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 2.938716e-01 | 0.532 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.485174e-01 | 0.605 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.429697e-01 | 0.465 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 2.389935e-01 | 0.622 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 3.087485e-01 | 0.510 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.317445e-01 | 0.635 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.317445e-01 | 0.635 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 2.581815e-01 | 0.588 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.416267e-01 | 0.466 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.429697e-01 | 0.465 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.013674e-01 | 0.521 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 3.245004e-01 | 0.489 | 0 | 0 |
| S Phase | R-HSA-69242 | 2.477629e-01 | 0.606 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 2.497720e-01 | 0.602 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 3.009309e-01 | 0.522 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.416267e-01 | 0.466 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.620541e-01 | 0.582 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.331514e-01 | 0.477 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.331514e-01 | 0.477 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.689714e-01 | 0.570 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.974026e-01 | 0.401 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.485174e-01 | 0.605 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.429697e-01 | 0.465 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.791311e-01 | 0.421 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 2.638603e-01 | 0.579 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 3.068752e-01 | 0.513 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.249900e-01 | 0.488 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 2.610286e-01 | 0.583 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.094772e-01 | 0.509 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.254961e-01 | 0.487 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.153422e-01 | 0.501 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 2.599592e-01 | 0.585 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 2.773948e-01 | 0.557 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.064290e-01 | 0.685 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.032453e-01 | 0.692 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.614099e-01 | 0.442 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 3.420214e-01 | 0.466 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 3.563624e-01 | 0.448 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.208315e-01 | 0.494 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.791311e-01 | 0.421 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.576750e-01 | 0.447 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.990178e-01 | 0.701 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 2.317445e-01 | 0.635 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.689714e-01 | 0.570 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.689714e-01 | 0.570 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.219211e-01 | 0.654 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.219211e-01 | 0.654 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.219211e-01 | 0.654 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.429697e-01 | 0.465 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.492368e-01 | 0.603 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 3.812199e-01 | 0.419 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.638603e-01 | 0.579 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 2.829823e-01 | 0.548 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.150797e-01 | 0.667 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 2.834105e-01 | 0.548 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 2.691532e-01 | 0.570 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.622039e-01 | 0.581 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.317445e-01 | 0.635 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.974026e-01 | 0.401 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.276604e-01 | 0.643 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 3.429697e-01 | 0.465 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.302863e-01 | 0.481 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.483987e-01 | 0.605 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.208315e-01 | 0.494 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.016356e-01 | 0.695 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 2.788685e-01 | 0.555 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 3.935001e-01 | 0.405 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 3.095554e-01 | 0.509 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.390021e-01 | 0.622 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.233213e-01 | 0.490 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.055490e-01 | 0.515 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 3.974026e-01 | 0.401 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 3.160482e-01 | 0.500 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.462799e-01 | 0.609 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 3.179689e-01 | 0.498 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 3.429697e-01 | 0.465 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.791311e-01 | 0.421 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 2.638603e-01 | 0.579 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.724211e-01 | 0.565 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.086124e-01 | 0.681 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.877491e-01 | 0.411 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.712234e-01 | 0.567 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 2.157062e-01 | 0.666 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.450508e-01 | 0.611 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.061591e-01 | 0.514 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.429697e-01 | 0.465 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 3.028652e-01 | 0.519 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.065922e-01 | 0.685 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.266145e-01 | 0.645 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.735206e-01 | 0.428 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 3.411891e-01 | 0.467 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 2.829823e-01 | 0.548 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.245004e-01 | 0.489 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.345096e-01 | 0.476 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 2.935246e-01 | 0.532 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.791311e-01 | 0.421 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 3.876673e-01 | 0.412 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.995983e-01 | 0.398 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 4.010059e-01 | 0.397 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.010059e-01 | 0.397 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 4.010059e-01 | 0.397 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 4.010059e-01 | 0.397 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.011149e-01 | 0.397 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.061068e-01 | 0.391 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.066783e-01 | 0.391 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 4.066783e-01 | 0.391 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 4.076696e-01 | 0.390 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.118483e-01 | 0.385 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 4.118483e-01 | 0.385 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 4.118483e-01 | 0.385 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.118883e-01 | 0.385 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 4.131093e-01 | 0.384 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.131093e-01 | 0.384 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.131093e-01 | 0.384 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 4.131093e-01 | 0.384 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.141581e-01 | 0.383 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 4.144267e-01 | 0.383 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.144267e-01 | 0.383 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 4.204850e-01 | 0.376 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 4.207195e-01 | 0.376 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 4.207195e-01 | 0.376 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.207195e-01 | 0.376 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.207195e-01 | 0.376 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.207195e-01 | 0.376 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 4.223838e-01 | 0.374 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 4.223838e-01 | 0.374 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.245548e-01 | 0.372 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.255380e-01 | 0.371 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.255380e-01 | 0.371 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.255380e-01 | 0.371 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 4.290915e-01 | 0.367 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 4.290915e-01 | 0.367 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.330882e-01 | 0.363 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 4.359926e-01 | 0.361 | 1 | 1 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 4.384141e-01 | 0.358 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 4.384141e-01 | 0.358 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.384141e-01 | 0.358 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.386142e-01 | 0.358 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.386142e-01 | 0.358 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 4.388305e-01 | 0.358 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 4.403154e-01 | 0.356 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.404660e-01 | 0.356 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 4.481932e-01 | 0.349 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 4.484588e-01 | 0.348 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.484588e-01 | 0.348 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 4.486878e-01 | 0.348 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 4.486878e-01 | 0.348 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.486878e-01 | 0.348 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 4.486878e-01 | 0.348 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.486878e-01 | 0.348 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.486878e-01 | 0.348 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 4.487132e-01 | 0.348 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 4.512745e-01 | 0.346 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.512745e-01 | 0.346 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 4.512745e-01 | 0.346 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 4.512745e-01 | 0.346 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.554667e-01 | 0.342 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.554667e-01 | 0.342 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.554667e-01 | 0.342 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.554667e-01 | 0.342 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.554667e-01 | 0.342 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 4.554667e-01 | 0.342 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.554667e-01 | 0.342 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 4.554667e-01 | 0.342 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.554667e-01 | 0.342 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 4.565559e-01 | 0.341 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 4.571194e-01 | 0.340 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.584429e-01 | 0.339 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 4.597510e-01 | 0.337 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 4.618660e-01 | 0.335 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 4.635127e-01 | 0.334 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 4.641766e-01 | 0.333 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 4.645089e-01 | 0.333 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 4.645089e-01 | 0.333 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 4.645089e-01 | 0.333 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 4.645089e-01 | 0.333 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 4.645089e-01 | 0.333 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 4.659674e-01 | 0.332 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 4.708338e-01 | 0.327 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 4.731710e-01 | 0.325 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 4.731710e-01 | 0.325 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 4.731710e-01 | 0.325 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.789868e-01 | 0.320 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.817862e-01 | 0.317 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.817862e-01 | 0.317 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 4.817862e-01 | 0.317 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.817862e-01 | 0.317 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 4.817862e-01 | 0.317 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 4.817862e-01 | 0.317 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.817862e-01 | 0.317 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.817862e-01 | 0.317 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 4.867752e-01 | 0.313 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 4.900557e-01 | 0.310 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 4.900557e-01 | 0.310 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 4.947302e-01 | 0.306 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 4.947302e-01 | 0.306 | 0 | 0 |
| Translation | R-HSA-72766 | 4.952453e-01 | 0.305 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 4.979864e-01 | 0.303 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.979864e-01 | 0.303 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 4.979864e-01 | 0.303 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 4.979864e-01 | 0.303 | 1 | 1 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 4.979864e-01 | 0.303 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.005044e-01 | 0.301 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.025746e-01 | 0.299 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.043458e-01 | 0.297 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.079389e-01 | 0.294 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.079389e-01 | 0.294 | 0 | 0 |
| FGFR1c and Klotho ligand binding and activation | R-HSA-190374 | 5.079389e-01 | 0.294 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.079389e-01 | 0.294 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.079389e-01 | 0.294 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.079389e-01 | 0.294 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.079389e-01 | 0.294 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.079389e-01 | 0.294 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 5.079389e-01 | 0.294 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.079389e-01 | 0.294 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 5.079389e-01 | 0.294 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.079389e-01 | 0.294 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 5.079389e-01 | 0.294 | 0 | 0 |
| Toxicity of botulinum toxin type C (botC) | R-HSA-5250971 | 5.079389e-01 | 0.294 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.086219e-01 | 0.294 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 5.136279e-01 | 0.289 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.136279e-01 | 0.289 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.136279e-01 | 0.289 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.136279e-01 | 0.289 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.136279e-01 | 0.289 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.136279e-01 | 0.289 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 5.154437e-01 | 0.288 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 5.159065e-01 | 0.287 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.159065e-01 | 0.287 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.159065e-01 | 0.287 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 5.167162e-01 | 0.287 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.167162e-01 | 0.287 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.167162e-01 | 0.287 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.167162e-01 | 0.287 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.167162e-01 | 0.287 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 5.174791e-01 | 0.286 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.182114e-01 | 0.285 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 5.209191e-01 | 0.283 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 5.227656e-01 | 0.282 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.331319e-01 | 0.273 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 5.351458e-01 | 0.272 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 5.392534e-01 | 0.268 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 5.392534e-01 | 0.268 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.392534e-01 | 0.268 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.392534e-01 | 0.268 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.441478e-01 | 0.264 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 5.441478e-01 | 0.264 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.441478e-01 | 0.264 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 5.441478e-01 | 0.264 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.441478e-01 | 0.264 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 5.441478e-01 | 0.264 | 1 | 1 |
| Signal regulatory protein family interactions | R-HSA-391160 | 5.441478e-01 | 0.264 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 5.453118e-01 | 0.263 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 5.489204e-01 | 0.260 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 5.507213e-01 | 0.259 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 5.532479e-01 | 0.257 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 5.553577e-01 | 0.255 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.553577e-01 | 0.255 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.553577e-01 | 0.255 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.553577e-01 | 0.255 | 0 | 0 |
| Signaling by MST1 | R-HSA-8852405 | 5.553577e-01 | 0.255 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 5.553577e-01 | 0.255 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.553577e-01 | 0.255 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.553577e-01 | 0.255 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.553577e-01 | 0.255 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 5.553577e-01 | 0.255 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.553577e-01 | 0.255 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.553577e-01 | 0.255 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.553577e-01 | 0.255 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 5.553577e-01 | 0.255 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.553577e-01 | 0.255 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.553577e-01 | 0.255 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.553577e-01 | 0.255 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 5.564138e-01 | 0.255 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 5.569553e-01 | 0.254 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 5.569553e-01 | 0.254 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.569553e-01 | 0.254 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 5.569553e-01 | 0.254 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.616778e-01 | 0.251 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 5.628051e-01 | 0.250 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.628051e-01 | 0.250 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.628051e-01 | 0.250 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 5.639579e-01 | 0.249 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.669468e-01 | 0.246 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 5.678251e-01 | 0.246 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.733049e-01 | 0.242 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 5.733049e-01 | 0.242 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 5.733049e-01 | 0.242 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 5.733049e-01 | 0.242 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.733049e-01 | 0.242 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 5.733049e-01 | 0.242 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.733049e-01 | 0.242 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.733049e-01 | 0.242 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.767625e-01 | 0.239 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 5.767625e-01 | 0.239 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 5.849696e-01 | 0.233 | 1 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 5.856083e-01 | 0.232 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 5.856083e-01 | 0.232 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 5.856083e-01 | 0.232 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 5.856083e-01 | 0.232 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 5.882594e-01 | 0.230 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 5.882594e-01 | 0.230 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 5.883741e-01 | 0.230 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.933217e-01 | 0.227 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 5.933217e-01 | 0.227 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 5.949272e-01 | 0.226 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 5.960560e-01 | 0.225 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 5.960560e-01 | 0.225 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 5.960560e-01 | 0.225 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 5.960560e-01 | 0.225 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.982094e-01 | 0.223 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.982094e-01 | 0.223 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.982094e-01 | 0.223 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.982094e-01 | 0.223 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.982094e-01 | 0.223 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 5.982094e-01 | 0.223 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 5.982094e-01 | 0.223 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.982094e-01 | 0.223 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 5.982094e-01 | 0.223 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 5.982094e-01 | 0.223 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 5.982094e-01 | 0.223 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 6.010785e-01 | 0.221 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.010785e-01 | 0.221 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.010785e-01 | 0.221 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 6.053577e-01 | 0.218 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 6.076211e-01 | 0.216 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 6.076360e-01 | 0.216 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.076360e-01 | 0.216 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.076360e-01 | 0.216 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.122207e-01 | 0.213 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 6.148147e-01 | 0.211 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.159448e-01 | 0.210 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.163955e-01 | 0.210 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 6.197961e-01 | 0.208 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 6.197961e-01 | 0.208 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.212979e-01 | 0.207 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.219323e-01 | 0.206 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.219323e-01 | 0.206 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 6.219323e-01 | 0.206 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 6.219323e-01 | 0.206 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.266209e-01 | 0.203 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.269297e-01 | 0.203 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 6.274644e-01 | 0.202 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 6.274644e-01 | 0.202 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.274644e-01 | 0.202 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.274644e-01 | 0.202 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 6.274644e-01 | 0.202 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 6.274644e-01 | 0.202 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 6.274644e-01 | 0.202 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.274644e-01 | 0.202 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 6.288076e-01 | 0.201 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.288686e-01 | 0.201 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.288686e-01 | 0.201 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 6.288686e-01 | 0.201 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.369335e-01 | 0.196 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.369335e-01 | 0.196 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.369335e-01 | 0.196 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.369335e-01 | 0.196 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 6.369335e-01 | 0.196 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.369335e-01 | 0.196 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.369335e-01 | 0.196 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 6.369335e-01 | 0.196 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.369335e-01 | 0.196 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 6.369335e-01 | 0.196 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.369335e-01 | 0.196 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.376191e-01 | 0.195 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 6.380844e-01 | 0.195 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 6.389969e-01 | 0.195 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.401542e-01 | 0.194 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.422863e-01 | 0.192 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.492935e-01 | 0.188 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 6.492935e-01 | 0.188 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 6.492935e-01 | 0.188 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 6.492935e-01 | 0.188 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 6.492935e-01 | 0.188 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 6.523511e-01 | 0.186 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 6.523511e-01 | 0.186 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 6.524722e-01 | 0.185 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 6.524722e-01 | 0.185 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.524722e-01 | 0.185 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.524722e-01 | 0.185 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.524722e-01 | 0.185 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.542091e-01 | 0.184 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.577283e-01 | 0.182 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 6.580443e-01 | 0.182 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 6.689041e-01 | 0.175 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 6.689041e-01 | 0.175 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 6.690776e-01 | 0.175 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.695550e-01 | 0.174 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 6.709419e-01 | 0.173 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.716517e-01 | 0.173 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.716517e-01 | 0.173 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 6.719276e-01 | 0.173 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 6.719276e-01 | 0.173 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.719276e-01 | 0.173 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.719276e-01 | 0.173 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.719276e-01 | 0.173 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.719276e-01 | 0.173 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.719276e-01 | 0.173 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 6.719276e-01 | 0.173 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.719276e-01 | 0.173 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.719276e-01 | 0.173 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.719276e-01 | 0.173 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.719276e-01 | 0.173 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.761222e-01 | 0.170 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 6.761222e-01 | 0.170 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.761222e-01 | 0.170 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 6.761222e-01 | 0.170 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 6.761222e-01 | 0.170 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 6.761222e-01 | 0.170 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 6.761222e-01 | 0.170 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.842160e-01 | 0.165 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 6.842160e-01 | 0.165 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.853323e-01 | 0.164 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.860402e-01 | 0.164 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 6.860402e-01 | 0.164 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 6.876991e-01 | 0.163 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 6.876991e-01 | 0.163 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 6.876991e-01 | 0.163 | 1 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 6.876991e-01 | 0.163 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 6.876991e-01 | 0.163 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 6.899188e-01 | 0.161 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 6.899188e-01 | 0.161 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 6.967419e-01 | 0.157 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 6.984439e-01 | 0.156 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.984439e-01 | 0.156 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.984439e-01 | 0.156 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.996722e-01 | 0.155 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.001172e-01 | 0.155 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.001172e-01 | 0.155 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.001172e-01 | 0.155 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.001172e-01 | 0.155 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.035506e-01 | 0.153 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.035506e-01 | 0.153 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.035506e-01 | 0.153 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.035506e-01 | 0.153 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.035506e-01 | 0.153 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.035506e-01 | 0.153 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.035506e-01 | 0.153 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.035506e-01 | 0.153 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 7.056822e-01 | 0.151 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 7.056822e-01 | 0.151 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.056822e-01 | 0.151 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.056822e-01 | 0.151 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 7.056822e-01 | 0.151 | 1 | 1 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 7.121863e-01 | 0.147 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.122791e-01 | 0.147 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.154334e-01 | 0.145 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.194736e-01 | 0.143 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 7.194736e-01 | 0.143 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 7.194736e-01 | 0.143 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 7.228610e-01 | 0.141 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 7.228610e-01 | 0.141 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 7.228610e-01 | 0.141 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 7.268823e-01 | 0.139 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 7.278940e-01 | 0.138 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.321272e-01 | 0.135 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 7.321272e-01 | 0.135 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.321272e-01 | 0.135 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 7.321272e-01 | 0.135 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.321272e-01 | 0.135 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 7.321272e-01 | 0.135 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.341887e-01 | 0.134 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 7.344221e-01 | 0.134 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.348285e-01 | 0.134 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 7.356877e-01 | 0.133 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.392529e-01 | 0.131 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 7.392529e-01 | 0.131 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.392529e-01 | 0.131 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 7.402460e-01 | 0.131 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.543212e-01 | 0.122 | 1 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 7.548536e-01 | 0.122 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 7.548536e-01 | 0.122 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.548536e-01 | 0.122 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 7.548536e-01 | 0.122 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 7.578274e-01 | 0.120 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.578274e-01 | 0.120 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.578274e-01 | 0.120 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.578274e-01 | 0.120 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.579506e-01 | 0.120 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 7.579506e-01 | 0.120 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.579506e-01 | 0.120 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.579506e-01 | 0.120 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.579506e-01 | 0.120 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.579506e-01 | 0.120 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.579506e-01 | 0.120 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.579506e-01 | 0.120 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.579506e-01 | 0.120 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.579506e-01 | 0.120 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.579506e-01 | 0.120 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.579506e-01 | 0.120 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.579506e-01 | 0.120 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.631811e-01 | 0.117 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 7.662947e-01 | 0.116 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.662947e-01 | 0.116 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 7.662947e-01 | 0.116 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 7.662947e-01 | 0.116 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.667121e-01 | 0.115 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.696986e-01 | 0.114 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 7.696986e-01 | 0.114 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.696986e-01 | 0.114 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 7.696986e-01 | 0.114 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 7.696986e-01 | 0.114 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 7.709149e-01 | 0.113 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 7.748952e-01 | 0.111 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.752455e-01 | 0.111 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.752455e-01 | 0.111 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 7.752455e-01 | 0.111 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 7.795572e-01 | 0.108 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.801298e-01 | 0.108 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.812860e-01 | 0.107 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 7.812860e-01 | 0.107 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 7.812860e-01 | 0.107 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.812860e-01 | 0.107 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.812860e-01 | 0.107 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.812860e-01 | 0.107 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.812860e-01 | 0.107 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 7.812860e-01 | 0.107 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.812860e-01 | 0.107 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.812860e-01 | 0.107 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 7.833737e-01 | 0.106 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 7.838007e-01 | 0.106 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 7.838007e-01 | 0.106 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 7.838007e-01 | 0.106 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 7.879262e-01 | 0.104 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.915575e-01 | 0.102 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.915575e-01 | 0.102 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.915575e-01 | 0.102 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.915575e-01 | 0.102 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.915832e-01 | 0.102 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 7.941593e-01 | 0.100 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.952871e-01 | 0.099 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 7.971806e-01 | 0.098 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.971806e-01 | 0.098 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.015566e-01 | 0.096 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 8.023729e-01 | 0.096 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 8.023729e-01 | 0.096 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.023729e-01 | 0.096 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.023729e-01 | 0.096 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.023729e-01 | 0.096 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.023729e-01 | 0.096 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.023729e-01 | 0.096 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.023729e-01 | 0.096 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 8.061150e-01 | 0.094 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 8.066671e-01 | 0.093 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 8.068147e-01 | 0.093 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 8.068147e-01 | 0.093 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 8.068147e-01 | 0.093 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.098605e-01 | 0.092 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.098605e-01 | 0.092 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.098605e-01 | 0.092 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.098605e-01 | 0.092 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.098605e-01 | 0.092 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.130459e-01 | 0.090 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.158246e-01 | 0.088 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.170717e-01 | 0.088 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.175264e-01 | 0.087 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.210689e-01 | 0.086 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 8.210689e-01 | 0.086 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.210689e-01 | 0.086 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.210689e-01 | 0.086 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.214279e-01 | 0.085 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 8.214279e-01 | 0.085 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.214279e-01 | 0.085 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 8.214279e-01 | 0.085 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.214279e-01 | 0.085 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.214279e-01 | 0.085 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.214279e-01 | 0.085 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.214279e-01 | 0.085 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.214279e-01 | 0.085 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.218637e-01 | 0.085 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 8.221212e-01 | 0.085 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.265627e-01 | 0.083 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 8.278788e-01 | 0.082 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.332142e-01 | 0.079 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.332142e-01 | 0.079 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.332142e-01 | 0.079 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 8.332142e-01 | 0.079 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.343716e-01 | 0.079 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 8.343716e-01 | 0.079 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.343716e-01 | 0.079 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.343716e-01 | 0.079 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.343716e-01 | 0.079 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 8.356503e-01 | 0.078 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.377384e-01 | 0.077 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.386466e-01 | 0.076 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.386466e-01 | 0.076 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.386466e-01 | 0.076 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.386466e-01 | 0.076 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.386466e-01 | 0.076 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 8.386466e-01 | 0.076 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 8.386466e-01 | 0.076 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.386466e-01 | 0.076 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.386466e-01 | 0.076 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 8.386466e-01 | 0.076 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.439365e-01 | 0.074 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 8.439365e-01 | 0.074 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 8.443443e-01 | 0.073 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.467736e-01 | 0.072 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.467736e-01 | 0.072 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.467736e-01 | 0.072 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.480188e-01 | 0.072 | 1 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.522125e-01 | 0.069 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 8.522509e-01 | 0.069 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 8.540556e-01 | 0.069 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.540556e-01 | 0.069 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.540556e-01 | 0.069 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.540556e-01 | 0.069 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.542059e-01 | 0.068 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.542059e-01 | 0.068 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.542059e-01 | 0.068 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.542059e-01 | 0.068 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.542059e-01 | 0.068 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.542059e-01 | 0.068 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 8.542059e-01 | 0.068 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.566107e-01 | 0.067 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.583250e-01 | 0.066 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.583250e-01 | 0.066 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 8.583250e-01 | 0.066 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.583250e-01 | 0.066 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 8.635966e-01 | 0.064 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.635966e-01 | 0.064 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.635966e-01 | 0.064 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 8.665763e-01 | 0.062 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.682657e-01 | 0.061 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.682657e-01 | 0.061 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 8.682657e-01 | 0.061 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 8.682657e-01 | 0.061 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.682657e-01 | 0.061 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 8.682657e-01 | 0.061 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.682657e-01 | 0.061 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.682657e-01 | 0.061 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.682657e-01 | 0.061 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.682657e-01 | 0.061 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.690744e-01 | 0.061 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.725843e-01 | 0.059 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 8.725843e-01 | 0.059 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.785252e-01 | 0.056 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.790691e-01 | 0.056 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 8.790691e-01 | 0.056 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 8.792699e-01 | 0.056 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.801793e-01 | 0.055 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.809704e-01 | 0.055 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.809704e-01 | 0.055 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.809704e-01 | 0.055 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.809704e-01 | 0.055 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.809704e-01 | 0.055 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.809704e-01 | 0.055 | 0 | 0 |
| Biosynthesis of maresin-like SPMs | R-HSA-9027307 | 8.809704e-01 | 0.055 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 8.809704e-01 | 0.055 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.809704e-01 | 0.055 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.809704e-01 | 0.055 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 8.822205e-01 | 0.054 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 8.858519e-01 | 0.053 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.883545e-01 | 0.051 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.901498e-01 | 0.051 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 8.905463e-01 | 0.050 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.924505e-01 | 0.049 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.924505e-01 | 0.049 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 8.924505e-01 | 0.049 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 8.924505e-01 | 0.049 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 8.924505e-01 | 0.049 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.924505e-01 | 0.049 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.956014e-01 | 0.048 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.964752e-01 | 0.047 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 8.964752e-01 | 0.047 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 8.969746e-01 | 0.047 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.969746e-01 | 0.047 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.975215e-01 | 0.047 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 8.989967e-01 | 0.046 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 9.028240e-01 | 0.044 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 9.028240e-01 | 0.044 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 9.028240e-01 | 0.044 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.028240e-01 | 0.044 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.028240e-01 | 0.044 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.028240e-01 | 0.044 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.067474e-01 | 0.043 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.068450e-01 | 0.042 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.068450e-01 | 0.042 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.100814e-01 | 0.041 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.120192e-01 | 0.040 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.121974e-01 | 0.040 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.121974e-01 | 0.040 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.121974e-01 | 0.040 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.121974e-01 | 0.040 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.123843e-01 | 0.040 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.123843e-01 | 0.040 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.126297e-01 | 0.040 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.192521e-01 | 0.037 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.192521e-01 | 0.037 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 9.192521e-01 | 0.037 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.192521e-01 | 0.037 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.206673e-01 | 0.036 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.206673e-01 | 0.036 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 9.206673e-01 | 0.036 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.206673e-01 | 0.036 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 9.206673e-01 | 0.036 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.219317e-01 | 0.035 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.232467e-01 | 0.035 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 9.232467e-01 | 0.035 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 9.232467e-01 | 0.035 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 9.237142e-01 | 0.034 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.256108e-01 | 0.034 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.283205e-01 | 0.032 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.283205e-01 | 0.032 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.283205e-01 | 0.032 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.283205e-01 | 0.032 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.283205e-01 | 0.032 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.283205e-01 | 0.032 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.314947e-01 | 0.031 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.314947e-01 | 0.031 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.325328e-01 | 0.030 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.345154e-01 | 0.029 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.352358e-01 | 0.029 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.352358e-01 | 0.029 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.352358e-01 | 0.029 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.352358e-01 | 0.029 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.372749e-01 | 0.028 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 9.414844e-01 | 0.026 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.414844e-01 | 0.026 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.414844e-01 | 0.026 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.414844e-01 | 0.026 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.414844e-01 | 0.026 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.414844e-01 | 0.026 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 9.417072e-01 | 0.026 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 9.419657e-01 | 0.026 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.427102e-01 | 0.026 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.442708e-01 | 0.025 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.448899e-01 | 0.025 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.448899e-01 | 0.025 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.449892e-01 | 0.025 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.458475e-01 | 0.024 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.458475e-01 | 0.024 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.466122e-01 | 0.024 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 9.466122e-01 | 0.024 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 9.471304e-01 | 0.024 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.471304e-01 | 0.024 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.471304e-01 | 0.024 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 9.471304e-01 | 0.024 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.471304e-01 | 0.024 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.471304e-01 | 0.024 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.471304e-01 | 0.024 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 9.471304e-01 | 0.024 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.471304e-01 | 0.024 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.488268e-01 | 0.023 | 0 | 0 |
| CYP2E1 reactions | R-HSA-211999 | 9.522319e-01 | 0.021 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.522319e-01 | 0.021 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.522319e-01 | 0.021 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.522319e-01 | 0.021 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.522319e-01 | 0.021 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.522319e-01 | 0.021 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.532192e-01 | 0.021 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.533027e-01 | 0.021 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.533199e-01 | 0.021 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.568415e-01 | 0.019 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.568415e-01 | 0.019 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.568415e-01 | 0.019 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.568415e-01 | 0.019 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.568415e-01 | 0.019 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.568415e-01 | 0.019 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.568415e-01 | 0.019 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.580150e-01 | 0.019 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.585159e-01 | 0.018 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.591319e-01 | 0.018 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.604315e-01 | 0.018 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 9.610065e-01 | 0.017 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.610065e-01 | 0.017 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.610065e-01 | 0.017 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.610065e-01 | 0.017 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.618847e-01 | 0.017 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.618847e-01 | 0.017 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.618847e-01 | 0.017 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.627411e-01 | 0.016 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.631242e-01 | 0.016 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.631242e-01 | 0.016 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.638175e-01 | 0.016 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.647697e-01 | 0.016 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.647697e-01 | 0.016 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.647697e-01 | 0.016 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.647697e-01 | 0.016 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.653232e-01 | 0.015 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.654618e-01 | 0.015 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.654618e-01 | 0.015 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.658919e-01 | 0.015 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.678510e-01 | 0.014 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.679944e-01 | 0.014 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.681700e-01 | 0.014 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.681700e-01 | 0.014 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.681700e-01 | 0.014 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.704862e-01 | 0.013 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.712423e-01 | 0.013 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.712423e-01 | 0.013 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.712423e-01 | 0.013 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 9.729124e-01 | 0.012 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.729124e-01 | 0.012 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.729124e-01 | 0.012 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 9.740182e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.740182e-01 | 0.011 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.740182e-01 | 0.011 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.760345e-01 | 0.011 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 9.765263e-01 | 0.010 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 9.765263e-01 | 0.010 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.765263e-01 | 0.010 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.771999e-01 | 0.010 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.772901e-01 | 0.010 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.772901e-01 | 0.010 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.772901e-01 | 0.010 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.787924e-01 | 0.009 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.787924e-01 | 0.009 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.787924e-01 | 0.009 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.798641e-01 | 0.009 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.808399e-01 | 0.008 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 9.808399e-01 | 0.008 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.808399e-01 | 0.008 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.824240e-01 | 0.008 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 9.826898e-01 | 0.008 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.826898e-01 | 0.008 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.834078e-01 | 0.007 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.843612e-01 | 0.007 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.843612e-01 | 0.007 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.852994e-01 | 0.006 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.858713e-01 | 0.006 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.858713e-01 | 0.006 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.864202e-01 | 0.006 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.864202e-01 | 0.006 | 1 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.872357e-01 | 0.006 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.872357e-01 | 0.006 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.872357e-01 | 0.006 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.872357e-01 | 0.006 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.876142e-01 | 0.005 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.882975e-01 | 0.005 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.884684e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.884684e-01 | 0.005 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.884684e-01 | 0.005 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.885033e-01 | 0.005 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.886575e-01 | 0.005 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.895821e-01 | 0.005 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.912989e-01 | 0.004 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 9.914974e-01 | 0.004 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.914974e-01 | 0.004 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.920377e-01 | 0.003 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.920377e-01 | 0.003 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.922576e-01 | 0.003 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 9.923187e-01 | 0.003 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.927149e-01 | 0.003 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.927149e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.930607e-01 | 0.003 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.930607e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.930607e-01 | 0.003 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.930607e-01 | 0.003 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.931551e-01 | 0.003 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.931551e-01 | 0.003 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.932808e-01 | 0.003 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.933357e-01 | 0.003 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.943367e-01 | 0.002 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.944528e-01 | 0.002 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.945611e-01 | 0.002 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.945611e-01 | 0.002 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.948839e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.948839e-01 | 0.002 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.953783e-01 | 0.002 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.953783e-01 | 0.002 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.953783e-01 | 0.002 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.953783e-01 | 0.002 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.954407e-01 | 0.002 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.957408e-01 | 0.002 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.962283e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.965256e-01 | 0.002 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.965256e-01 | 0.002 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 9.965928e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.967499e-01 | 0.001 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.967983e-01 | 0.001 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.969221e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.969221e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.970308e-01 | 0.001 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.972196e-01 | 0.001 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.974884e-01 | 0.001 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.975229e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.979506e-01 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.984287e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.985673e-01 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.986354e-01 | 0.001 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.988059e-01 | 0.001 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.988865e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.989279e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.989279e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.989942e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.990915e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.990915e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.991883e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.992587e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.993305e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.993305e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.993661e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.993958e-01 | 0.000 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.994067e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.994497e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.995066e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.995259e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.995419e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.995543e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.995543e-01 | 0.000 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.995553e-01 | 0.000 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.995617e-01 | 0.000 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.996229e-01 | 0.000 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 9.996716e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.996716e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.997034e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.997573e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.997804e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.997963e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.998301e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.998814e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.998979e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.999356e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999543e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999559e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999567e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999572e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999621e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999670e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999682e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.999715e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999768e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999780e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.999790e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999811e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999860e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999924e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999938e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999949e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999956e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999958e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999958e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999959e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999963e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999965e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999970e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999974e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999979e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999980e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999985e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999991e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999993e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999997e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999997e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999999e-01 | 0.000 | 1 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 9.999999e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999999e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 1 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |